<PAGE>
Pursuant to Rule 424(b)2
Registration No. 033-53651
PROSPECTUS SUPPLEMENT
(TO PROSPECTUS DATED FEBRUARY 17, 1998)
$13,000,000
LEHMAN BROTHERS HOLDINGS INC.
NOTES DUE NOVEMBER 14, 2007
PERFORMANCE LINKED TO PFIZER INC. (PFE) COMMON STOCK
---------------------------
GENERAL:
o Senior unsecured debt securities of Lehman Brothers Holdings.
o Performance linked to the common stock of Pfizer Inc. Pfizer is not
involved in this offering and has no obligation with respect to the notes.
o Denominations: $1,000 and whole multiples of $1,000.
o Stated maturity date: November 14, 2007, subject to postponement if a
market disruption event occurs.
PAYMENTS:
o Lehman Brothers Holdings will pay you interest semi-annually at a rate
equal to 0.25% per year, beginning May 14, 2001.
o On the stated maturity date, Lehman Brothers Holdings will pay to you, per
$1,000 note, the greater of:
(1) $1,000, plus accrued but unpaid interest; and
(2) the alternative redemption amount, plus accrued but unpaid interest.
The alternative redemption amount per $1,000 note is equal to the
settlement value on the stated maturity date, multiplied by a conversion
ratio determined by dividing $1,000 by $52.3790, which represents 114.40%
of $45.7858. $45.7858 is the average execution price for Pfizer common
stock that an affiliate of Lehman Brothers Holdings paid to hedge Lehman
Brothers Holdings' obligations under the notes.
The settlement value on the stated maturity date will be the closing price
of the Pfizer common stock on the third business day before the stated
maturity date. The settlement value will reflect certain extraordinary
transactions involving Pfizer.
You can calculate the alternative redemption amount using the following
formula:
$1,000
------
$52.3790 x the settlement value
As a result, you will only receive the alternative redemption amount if, on
the stated maturity date, the settlement value is greater than $52.3790.
o On or after November 9, 2002, Lehman Brothers Holdings may redeem each
$1,000 note at a price equal to the amount that would be payable to you at
the stated maturity date, but calculated as of the third business day
before the redemption date, plus accrued but unpaid interest.
o At any time until eight business days before November 9, 2007, you may
require Lehman Brothers Holdings to repurchase each $1,000 note at a price
equal to the alternative redemption amount, calculated as of the third
business day before the repurchase date, plus accrued but unpaid interest.
o Listing: Application will be made to list the notes on the American Stock
Exchange under the symbol "PZR.A."
INVESTING IN THE NOTES INVOLVES RISKS. RISK FACTORS BEGIN ON PAGE S-6.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined that
this prospectus supplement or the accompanying prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.
---------------------------
<TABLE>
<CAPTION>
PER NOTE TOTAL
-------- -----
<S> <C> <C>
Public offering price........................... 100% $13,000,000
Underwriting discount........................... 0% $0
Proceeds to Lehman Brothers Holdings............ 100% $13,000,000
</TABLE>
---------------------------
The notes are expected to be ready for delivery in book-entry form only through
The Depository Trust Company on or about November 14, 2000. Lehman Brothers
Inc., a wholly-owned subsidiary of Lehman Brothers Holdings, makes a market in
Lehman Brothers Holdings' securities. It may act as principal or agent in, and
this prospectus may be used in connection with, those transactions. Any such
sales will be made at varying prices related to prevailing market prices at the
time of sale.
---------------------------
LEHMAN BROTHERS
<PAGE>
YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY
REFERENCE IN THIS PROSPECTUS SUPPLEMENT AND THE ACCOMPANYING PROSPECTUS. NO ONE
HAS BEEN AUTHORIZED TO PROVIDE YOU WITH DIFFERENT INFORMATION. YOU SHOULD NOT
ASSUME THAT THE INFORMATION CONTAINED IN THIS PROSPECTUS SUPPLEMENT OR THE
ACCOMPANYING PROSPECTUS IS ACCURATE AS OF ANY DATE OTHER THAN THE DATE ON THE
FRONT COVER OF THE DOCUMENT. SECURITIES ARE NOT BEING OFFERED IN ANY
JURISDICTION WHERE THE OFFER IS NOT PERMITTED.
---------------------------
TABLE OF CONTENTS
PAGE
----
PROSPECTUS SUPPLEMENT
SUMMARY INFORMATION--Q&A.....................................................S-3
RISK FACTORS.................................................................S-6
USE OF PROCEEDS AND HEDGING..................................................S-8
RATIO OF EARNINGS TO FIXED CHARGES...........................................S-9
DESCRIPTION OF THE NOTES.....................................................S-9
PFIZER COMMON STOCK.........................................................S-17
UNITED STATES FEDERAL INCOME TAX CONSEQUENCES...............................S-18
BOOK-ENTRY ISSUANCE.........................................................S-21
UNDERWRITING................................................................S-22
EXPERTS.....................................................................S-23
PROSPECTUS
AVAILABLE INFORMATION..........................................................2
DOCUMENTS INCORPORATED BY REFERENCE............................................2
THE COMPANY....................................................................3
USE OF PROCEEDS................................................................3
RATIO OF EARNINGS TO FIXED CHARGES.............................................3
DESCRIPTION OF DEBT SECURITIES.................................................4
DESCRIPTION OF WARRANTS.......................................................12
GLOBAL SECURITIES.............................................................18
UNITED STATES TAXATION........................................................20
CAPITAL REQUIREMENTS..........................................................20
PLAN OF DISTRIBUTION..........................................................21
ERISA MATTERS.................................................................22
LEGAL OPINIONS................................................................22
INDEPENDENT ACCOUNTANTS.......................................................23
S-2
<PAGE>
SUMMARY INFORMATION--Q&A
This summary highlights selected information from the prospectus supplement and
accompanying prospectus to help you understand the notes. You should carefully
read this prospectus supplement and the accompanying prospectus to understand
fully the terms of the notes and the tax and other considerations that are
important to you in making a decision about whether to invest in the notes. You
should pay special attention to the "Risk Factors" section beginning on page S-6
to determine whether an investment in the notes is appropriate for you. For your
convenience, there are references throughout this document to specific page
numbers where more detailed information on some of the terms and concepts
discussed can be found.
WHAT ARE THE NOTES?
The notes are a series of senior debt of Lehman Brothers Holdings whose value is
tied to the performance of Pfizer common stock. See "Pfizer Common Stock"
beginning on page S-17. The notes will rank equally with all other unsecured
debt of Lehman Brothers Holdings, except subordinated debt, and will mature on
November 14, 2007 unless postponed because a market disruption event occurs. See
"Description of the Notes--Determination of alternative redemption amount"
beginning on page S-10.
WHAT PAYMENTS WILL I RECEIVE ON THE NOTES?
Lehman Brothers Holdings will pay you interest semi-annually at a rate of 0.25%
per year, beginning May 14, 2001. You will also receive a payment at the
redemption, the repurchase or the stated maturity of the notes.
WHAT WILL I RECEIVE IF I HOLD THE NOTES UNTIL THE STATED MATURITY DATE?
Lehman Brothers Holdings has designed the notes for investors who want to
protect their investment by receiving at least the principal amount of their
investment on the stated maturity date and who also want to participate in a
possible increase in the market price of Pfizer common stock. On the stated
maturity date, you will receive a payment per $1,000 note equal to the greater
of:
o $1,000, plus accrued but unpaid interest; and
o the alternative redemption amount, plus accrued but unpaid interest.
As a result, if you hold the notes until the stated maturity date, you will not
receive less than the principal amount.
HOW DOES THE REDEMPTION FEATURE WORK?
Lehman Brothers Holdings may redeem all or part of the notes on one or more
occasions on or after November 9, 2002 at a redemption price per $1,000 note
equal to the greater of:
o $1,000, plus accrued but unpaid interest; and
o the alternative redemption amount, calculated as of the third business day
before the redemption date, plus accrued but unpaid interest.
As a result, if Lehman Brothers Holdings redeems your notes, you will not
receive less than the principal amount.
Citibank, N.A., the trustee for the notes, will give you at least 30 days'
notice of any redemption.
HOW CAN YOU REQUIRE LEHMAN BROTHERS HOLDINGS TO REPURCHASE YOUR NOTES?
At any time until eight business days before November 9, 2007, you may instruct
Lehman Brothers Holdings to repurchase all or part of your notes at a price per
$1,000 note equal to the alternative redemption amount, calculated as of the
third business day before the repurchase date, plus accrued but unpaid interest,
by giving Lehman Brothers Holdings notice on any business day at the corporate
trust office of Citibank, N.A., the trustee for the notes. The repurchase date
will be the eighth business day following the business day when Lehman Brothers
Holdings has received your notice, unless payment is postponed because a market
disruption event occurs. See "Description of the Notes--Determination of
alternative redemption amount" beginning on page S-10.
If Lehman Brothers Holdings repurchases your notes, the amount you receive may
be greater or less than $1,000 per $1,000 note.
HOW WILL THE ALTERNATIVE REDEMPTION AMOUNT BE CALCULATED?
The alternative redemption amount per $1,000 note will be calculated by the
following formula:
$1,000
------
$52.3790 x the settlement value
This formula accounts for the fact that the settlement value, on the stated
maturity date, must be greater than
S-3
<PAGE>
$52.3790 for you to receive any amount above $1,000 per $1,000 note and the
portion of any increase that you will receive if the settlement value is greater
than 52.3790. $52.3790 represents 114.40% of $45.7858, which is the average
execution price for Pfizer common stock that an affiliate of Lehman Brothers
Holdings paid to hedge Lehman Brothers Holdings' obligations under the notes.
The settlement value on the stated maturity date or upon redemption or
repurchase will generally be the closing price of the Pfizer common stock on the
third business day prior to the stated maturity date, the redemption date or the
repurchase date, as the case may be. The settlement value will also include any
other equity securities or any cash received by a holder of Pfizer common stock
as a result of extraordinary corporate transactions as described below. See
"Description of the Notes--Determination of alternative redemption amount"
beginning on page S-10 for details.
ALTERNATIVE REDEMPTION AMOUNT--EXAMPLES
Here are two examples of hypothetical alternative redemption amount
calculations:
EXAMPLE 1: THE SETTLEMENT VALUE IS $50.
Alternative redemption amount per $1,000 note =
$1,000
------------
$52.3790 x $50 = $954.58
As a result, on the stated maturity date or upon redemption, you will receive
$1,000, plus accrued but unpaid interest, per $1,000 note because $1,000 is
greater than $954.58. If you require Lehman Brothers Holdings to repurchase your
notes, you will only receive $954.58, plus accrued but unpaid interest, per
$1,000 note.
EXAMPLE 2: THE SETTLEMENT VALUE IS $60.
Alternative redemption amount per $1,000 note =
$1,000
------------
$52.3790 x $60 = $1,145.50
As a result, on the stated maturity date or upon redemption, you will receive
$1,145.50, plus accrued but unpaid interest, per $1,000 note because $1,145.50
is greater than $1,000. If you require Lehman Brothers Holdings to repurchase
your notes, you will also receive $1,145.50, plus accrued but unpaid interest,
per $1,000 note.
HOW HAS THE PFIZER COMMON STOCK PERFORMED HISTORICALLY?
Lehman Brothers Holdings has provided a table, beginning on page S-17, showing
the performance of Pfizer common stock from 1995 through November 8, 2000.
Lehman Brothers Holdings has provided this historical information to help you
evaluate the behavior of the Pfizer common stock so that you can make an
informed decision with respect to an investment in the notes. You should
realize, however, that past performance is not necessarily indicative of how
Pfizer common stock or the notes will perform in the future.
WHAT CHANGES WILL BE MADE TO THE SETTLEMENT VALUE?
Changes will be made to the settlement value if Pfizer or other issuers whose
securities are included in the calculation of the settlement value engage in
extraordinary transactions. For example, if Pfizer is not the surviving entity
in a merger, its common stock will be removed from the calculation of the
settlement value and the settlement value will then include equity securities of
the successor entity or cash received in the merger plus accrued interest. Also
as an example, if Pfizer distributes equity securities of a subsidiary to
shareholders, the subsidiary's equity securities will then be added to the
settlement value. See "Description of the Notes--Adjustments to securities
included in the calculation of the settlement value" beginning on page S-11.
HOW WILL I BE ABLE TO FIND THE SETTLEMENT VALUE?
You may call Lehman Brothers Inc. at 212-526-0900 to obtain the settlement value
and the number of shares of Pfizer common stock and other equity securities
included in the calculation of the settlement value per $1,000 note. Pfizer
common stock is listed on the New York Stock Exchange under the symbol "PFE."
ARE THERE ANY RISKS ASSOCIATED WITH MY INVESTMENT?
Yes, the notes are subject to a number of risks. See "Risk Factors" beginning on
page S-6.
WHAT ABOUT TAXES?
The notes will be subject to U.S. Treasury regulations that apply to contingent
payment debt instruments. As a result, you will be subject to federal income tax
on the accrual of original issue discount in respect of the notes. In addition,
gain or loss on the sale, exchange or other disposition will generally be
ordinary gain or loss. See "United States Federal Income Tax Consequences"
beginning on page S-18.
S-4
<PAGE>
WHO IS LEHMAN BROTHERS HOLDINGS?
Lehman Brothers Holdings is one of the leading global investment banks, serving
institutional, corporate, government and high net worth clients and customers.
Lehman Brothers Holdings' worldwide headquarters in New York and regional
headquarters in London and Tokyo are complemented by offices in additional
locations in the United States, Europe, the Middle East, Latin America and the
Asia Pacific region. See "Available Information," "Documents Incorporated By
Reference" and "The Company" on pages 2 and 3 of the accompanying prospectus.
WHAT IS THE ROLE OF LEHMAN BROTHERS INC.?
Lehman Brothers Inc., a subsidiary of Lehman Brothers Holdings, is the
underwriter for the offering and sale of the notes. Lehman Brothers Inc. will
also be the calculation agent for purposes of calculating the amount payable to
you. Potential conflicts of interest may exist between Lehman Brothers Inc. and
you as a beneficial owner of the notes. See "Risk Factors--Potential conflicts
of interest exist because Lehman Brothers Holdings controls Lehman Brothers
Inc., which acts as the calculation agent" on page S-8 and "Description of the
Notes--Calculation agent" beginning on page S-15.
After the initial offering, Lehman Brothers Inc. intends to buy and sell the
notes to create a secondary market in the notes and may stabilize or maintain
the market price of the notes during the initial distribution of the notes.
However, Lehman Brothers Inc. will not be obligated to engage in any of these
market activities or to continue them once they are begun.
IN WHAT FORM WILL THE NOTES BE ISSUED?
The notes will be represented by one or more global securities that will be
deposited with and registered in the name of The Depository Trust Company or its
nominee. This means that you will not receive a certificate for your notes.
WILL THE NOTES BE LISTED ON A STOCK EXCHANGE?
Lehman Brothers Holdings will apply to list the notes on the American Stock
Exchange under the symbol "PZR.A." You should be aware that the listing of the
notes on the American Stock Exchange, if accepted, will not necessarily ensure
that a liquid market will be available for the notes.
S-5
<PAGE>
RISK FACTORS
You should carefully consider the risk factors provided below as well as the
other information contained in this prospectus supplement, the accompanying
prospectus and the documents incorporated in this document by reference. As
described in more detail below, the trading price of the notes may vary
considerably prior to the maturity date due, among other things, to fluctuations
in the price of Pfizer common stock and any other equity securities included in
the calculation of the settlement value and other events that are difficult to
predict and beyond Lehman Brothers Holdings' control.
You should reach an investment decision only after you have carefully considered
with your advisors the suitability of an investment in notes in light of your
particular circumstances.
THESE NOTES ARE DIFFERENT FROM CONVENTIONAL DEBT SECURITIES OF LEHMAN BROTHERS
HOLDINGS IN SEVERAL WAYS.
o THE YIELD MAY BE LOWER THAN THE YIELD ON A CONVENTIONAL DEBT SECURITY OF
COMPARABLE MATURITY. The amount Lehman Brothers Holdings pays you on the
stated maturity date may be less than the return you could earn on other
investments. Because the amount you receive on the stated maturity date may
be equal to or only slightly greater than $1,000 per $1,000 note, the
effective yield to maturity on the notes may be less than that which would
be payable on a conventional fixed-rate, non-callable debt security of
Lehman Brothers Holdings. In addition, any return may not fully compensate
you for any opportunity cost to you when you take into account inflation
and other factors relating to the time value of money.
o IF THE ALTERNATIVE REDEMPTION AMOUNT IS LESS THAN $1,000 PER $1,000 NOTE,
YOU WILL ONLY RECEIVE THE PRINCIPAL AMOUNT OF THE NOTES ON THE STATED
MATURITY DATE, PLUS ACCRUED BUT UNPAID INTEREST. This may be true even if
the settlement value exceeds $45.7858 at some time during the life of the
notes because the settlement value must, on the stated maturity date, be
greater than $52.3790 before the alternative redemption amount becomes
greater than $1,000 per $1,000 note.
o THE RATE OF INTEREST PAID ON THE NOTES IS SIGNIFICANTLY LESS THAN INTEREST
PAID ON A CONVENTIONAL DEBT SECURITY. The interest rate on the notes is
only 0.25% per year. However, because the notes will be classified as
contingent payment debt instruments, they will be considered to be issued
with original issue discount. As a result, you will be required to include
the original issue discount in income during your ownership of the notes,
subject to some adjustments. See "United States Federal Income Tax
Consequences" beginning on page S-18.
YOUR RETURN ON THE NOTES COULD BE LESS THAN IF YOU OWNED PFIZER COMMON STOCK.
o YOU WILL NOT RECEIVE ANY APPRECIATION UNLESS THE SETTLEMENT VALUE, ON THE
STATED MATURITY DATE, IS GREATER THAN $52.3790. Because you will not
receive any appreciation unless the settlement value, on the stated
maturity date, is greater than $52.3790, your return on the notes could be
less than the return obtainable if you had owned Pfizer common stock. Even
if the settlement value, on the stated maturity date, is greater than
$52.3790, you will realize only a portion of the excess of the settlement
value over $52.3790.
o YOUR RETURN WILL NOT REFLECT DIVIDENDS ON THE PFIZER COMMON STOCK OR OTHER
EQUITY SECURITIES INCLUDED IN THE CALCULATION OF THE SETTLEMENT VALUE.Your
return on the notes will also not reflect the return you would realize if
you actually owned Pfizer common stock (or any other equity securities)
included in the settlement value and received the dividends paid on that
stock. This is because the calculation agent will calculate the amount
payable to you by reference to the price of Pfizer common stock (and any
other equity securities) without taking into consideration the value of
dividends paid on that stock.
HISTORICAL VALUES OF PFIZER COMMON STOCK SHOULD NOT BE TAKEN AS AN INDICATION OF
THE SETTLEMENT VALUE DURING THE TERM OF THE NOTES.
The trading price of the Pfizer common stock and other equity securities
included in the calculation of the settlement value and any cash included in the
settlement value will determine the settlement value. As a result, it is
impossible to predict how much the settlement value will equal on the stated
maturity date. Trading prices of the Pfizer common stock and other equity
securities included in the calculation of the settlement value will be
influenced by complex and interrelated political, economic, financial and other
factors that can affect the markets in which those securities are traded and the
values of Pfizer common stock and those other equity securities themselves.
S-6
<PAGE>
THE VALUE OF THE NOTES WILL BE AFFECTED BY NUMEROUS FACTORS, SOME OF WHICH ARE
RELATED IN COMPLEX WAYS.
The value of the notes in the secondary market will be affected by supply and
demand of the notes, the settlement value of the notes at that time and a number
of other factors, some of which are interrelated in complex ways. As a result,
the effect of any one factor may be offset or magnified by the effect of another
factor. The price at which you will be able to sell the notes prior to stated
maturity may be at a discount, which could be substantial, from their principal
amount, if, at that time, the settlement value is less than, equal to, or not
sufficiently above $52.3790. You will not participate in the Pfizer's common
stock's appreciation unless the settlement value, on the stated maturity date,
is greater than $52.3790. A change in a specific factor could have the following
impacts on the market value of the notes, assuming all other conditions remain
constant.
o REDEMPTION FEATURE. Lehman Brothers Holdings' ability to redeem the notes
prior to the stated maturity date is likely to limit the secondary market
price at which the notes will trade.
o VALUE. Lehman Brothers Holdings expects that the market value of the notes
will depend substantially on the amount, if any, by which the settlement
value at any given point in time exceeds $52.3790. If you decide to sell
your notes when the settlement value exceeds $52.3790, you may nonetheless
receive substantially less than the amount that would be payable on the
stated maturity date based on that settlement value because of expectations
that the settlement value will continue to fluctuate until the alternative
redemption amount is determined. If you decide to sell your notes when the
settlement value is below $52.3790, you can expect to receive less than the
principal amount of the note. Political, economic and other developments
that affect the stocks included in the calculation of the settlement value
may also affect the settlement value and, thus, the value of the notes.
o INTEREST RATES. Because the notes repay at least their principal amount on
the stated maturity date, the trading value of the notes will be affected
by changes in interest rates. In general, if U.S. interest rates increase,
the trading value of the notes may be adversely affected, and if U.S.
interest rates decrease, the trading value of the notes may be favorably
affected.
o VOLATILITY OF THE SETTLEMENT VALUE. Volatility is the term used to describe
the size and frequency of market fluctuations. If the volatility of the
settlement value increases or decreases, the trading value of the notes may
be adversely affected.
o MERGER AND ACQUISITION TRANSACTIONS. Pfizer common stock or other equity
securities included in the calculation of the settlement value may be
affected by mergers and acquisitions, which can contribute to volatility of
the settlement value. Additionally, as a result of a merger or acquisition,
the Pfizer common stock or other equity securities included in the
calculation of the settlement value may be replaced with a surviving or
acquiring entity's securities. The surviving or acquiring entity's
securities may not have the same characteristics as Pfizer common stock.
o TIME REMAINING TO MATURITY. The value of the notes may be affected by the
time remaining to maturity. As the time remaining to the maturity of the
notes decreases, this time value may decrease, adversely affecting the
trading value of the notes.
o DIVIDEND YIELDS. If dividend yields on Pfizer common stock or other equity
securities included in the calculation of the settlement value increase,
the value of the notes may be adversely affected because the settlement
value does not incorporate the value of those payments.
o LEHMAN BROTHERS HOLDINGS' CREDIT RATINGS, FINANCIAL CONDITION AND RESULTS.
Actual or anticipated changes in Lehman Brothers Holdings' credit ratings,
financial condition or results may affect the market value of the notes.
o ECONOMIC CONDITIONS AND EARNINGS PERFORMANCE OF PFIZER AND OTHER COMPANIES
WHOSE SECURITIES ARE INCLUDED IN THE SETTLEMENT VALUE. General economic
conditions and earnings results of Pfizer and other companies whose equity
securities are included in the calculation of the settlement value and real
or anticipated changes in those conditions or results may affect the market
value of the notes.
You should understand that the impact of one of the factors specified above,
such as an increase in interest rates, may offset some or all of any change in
the trading value of the notes attributable to another factor, such as an
increase in the settlement value. In general, assuming all relevant factors are
held constant, the effect on the trading value of the notes of a given change in
most of the factors listed above will be less it if occurs later than if it
occurs earlier in the term of the notes.
S-7
<PAGE>
LEHMAN BROTHERS HOLDINGS CANNOT CONTROL ACTIONS BY PFIZER OR THE OTHER COMPANIES
WHOSE EQUITY SECURITIES ARE INCLUDED IN THE CALCULATION OF THE SETTLEMENT VALUE.
Actions by Pfizer or any other company whose equity security is included in the
settlement value may have an adverse effect on the price of the Pfizer common
stock or that other equity security, the settlement value and the notes. In
addition, these companies are not involved in the offering of the notes and have
no obligations with respect to the notes, including any obligation to take
Lehman Brothers Holdings' or your interests into consideration for any reason.
These companies will not receive any of the proceeds of this offering of the
notes and are not responsible for, and have not participated in, the
determination of the timing of, prices for, or quantities of, the notes to be
issued. These companies are not involved with the administration, marketing or
trading of the notes and have no obligations with respect to the amount to be
paid to you on the stated maturity date.
POTENTIAL CONFLICTS OF INTEREST EXIST BECAUSE LEHMAN BROTHERS HOLDINGS CONTROLS
LEHMAN BROTHERS INC., WHICH WILL ACT AS THE CALCULATION AGENT.
Lehman Brothers Inc. will act as the calculation agent, which determines the
amount you will receive on the notes, whether adjustments should be made to the
settlement value and whether a market disruption event has occurred. As a
result, potential conflicts of interest may exist between Lehman Brothers Inc.
and you. See "Description of the Notes--Payment on the stated maturity date" on
page S-10, "--Market disruption events" on page S-13 and "Adjustments to
securities included in the calculation of the settlement value" on page S-11.
PURCHASES AND SALES OF PFIZER COMMON STOCK OR OTHER EQUITY SECURITIES INCLUDED
IN THE CALCULATION OF THE SETTLEMENT VALUE BY LEHMAN BROTHERS HOLDINGS AND ITS
AFFILIATES COULD AFFECT THE PRICES OF THE PFIZER COMMON STOCK OR THOSE OTHER
EQUITY SECURITIES OR THE SETTLEMENT VALUE.
Lehman Brothers Holdings and its affiliates, including Lehman Brothers Inc., may
from time to time buy or sell Pfizer common stock or other equity securities or
derivative instruments related to the Pfizer common stock or other equity
securities included in the calculation of the settlement value for their own
accounts in connection with their normal business practices or in connection
with hedging of Lehman Brothers Holdings' obligations under the notes. These
transactions could affect the prices of the Pfizer common stock or those other
equity securities. See "Use of Proceeds and Hedging" below.
HOLDERS OF NOTES WILL BE REQUIRED TO ACCRUE ORIGINAL ISSUE DISCOUNT IN INCOME.
For U.S. federal income tax purposes, the notes will be classified as contingent
payment debt instruments. As a result, they will be considered to be issued with
original issue discount, which you will be required to include in income during
your ownership of the notes, subject to some adjustments. Additionally, you will
generally be required to recognize ordinary income on the gain, if any, realized
on a sale, upon maturity, or other disposition of the notes. See "United States
Federal Income Tax Consequences" beginning on page S-18.
USE OF PROCEEDS AND HEDGING
An amount equal to approximately one-half of the proceeds to be received by
Lehman Brothers Holdings from the sale of the notes has been or will be used by
Lehman Brothers Holdings or one or more of its subsidiaries before and
immediately following the initial offering of the notes to acquire Pfizer common
stock. Lehman Brothers Holdings or one or more of its subsidiaries may also
acquire listed or over-the-counter options contracts in, or other derivative or
synthetic instruments related to, Pfizer common stock to hedge Lehman Brothers
Holdings' obligations under the notes. The balance of the proceeds will be used
for general corporate purposes. See "Use of Proceeds" on page 3 of the
accompanying prospectus.
From time to time after the initial offering and prior to the maturity of the
notes, depending on market conditions, including the market price of Pfizer
common stock and any other equity securities included in the calculation of the
settlement value, Lehman Brothers Holdings expects that it or one or more of its
subsidiaries will increase or decrease their initial hedging positions using
dynamic hedging techniques. Lehman Brothers Holdings or one or more of its
subsidiaries may take long or short positions in Pfizer common stock or those
other equity securities or in listed or over-the-counter options contracts or
other derivative or synthetic instruments related to Pfizer common stock or
those other equity securities. In addition, Lehman Brothers Holdings or one or
more of its subsidiaries may purchase or otherwise acquire a long or
S-8
<PAGE>
short position in notes from time to time and may, in their sole discretion,
hold or resell those notes. Lehman Brothers Holdings or one or more of its
subsidiaries may also take positions in other types of appropriate financial
instruments that may become available in the future.
To the extent that Lehman Brothers Holdings or one or more of its subsidiaries
has a long hedge position in Pfizer common stock or other equity securities
included in the calculation of the settlement value, or option contracts or
other derivative or synthetic instruments related to Pfizer common stock or
those other equity securities, Lehman Brothers Holdings or one or more of its
subsidiaries may liquidate a portion of their holdings at or about the time of
the maturity of the notes or at or about the time of a change in the securities
included in the calculation of the settlement value. Depending, among other
things, on future market conditions, the aggregate amount and the composition of
the positions are likely to vary over time. Profits or losses from any of those
positions cannot be ascertained until the position is closed out and any
offsetting position or positions are taken into account. Certain activity by
Lehman Brothers Holdings or one or more of its subsidiaries described above can
potentially increase or decrease the price of Pfizer common stock or other
equity securities included in the calculation of the settlement value and,
accordingly, increase or decrease the settlement value. Although Lehman Brothers
Holdings has no reason to believe that any of those activities will have a
material impact on the price of Pfizer common stock or those other equity
securities, these activities could have such an effect.
RATIO OF EARNINGS TO FIXED CHARGES
<TABLE>
<CAPTION>
NINE MONTHS
YEAR ENDED NOVEMBER 30, ENDED
--------------------------------------------------------- AUGUST 31,
1995 1996 1997 1998 1999 2000
---- ---- ---- ---- ---- -----------
<S> <C> <C> <C> <C> <C>
1.03 1.06 1.07 1.07 1.12 1.14
</TABLE>
In computing the ratios for Lehman Brothers Holdings above, "earnings" consist
of earnings from continuing operations before income taxes and fixed charges;
and "fixed charges" consist principally of interest expense, capitalized
interest and the interest factor in rentals.
DESCRIPTION OF THE NOTES
GENERAL
You will find information about the notes in two separate documents that
progressively provide more detail:
o the accompanying prospectus; and
o this prospectus supplement.
Because the terms of the notes may differ from the general information Lehman
Brothers Holdings has provided in the prospectus, in all cases you should rely
on information in this prospectus supplement over different information in the
prospectus. The notes are to be issued as a series of debt securities under the
senior indenture, which is more fully described in the prospectus. For a
description of the rights attaching to different series of debt securities under
the senior indenture, you should refer to the section "Description of Debt
Securities" beginning on page 4 of the accompanying prospectus. The notes are
Senior Debt as described in the accompanying prospectus. Citibank, N.A. is
trustee under the senior indenture.
Lehman Brothers Holdings may initially issue up to $13,000,000 aggregate
principal amount of notes. Lehman Brothers Holdings may, without the consent of
the holders of the notes, create and issue additional notes ranking equally with
the notes and otherwise similar in all respects so that such further notes shall
be consolidated and form a single series with the notes. No additional notes can
be issued if an event of default has occurred with respect to the notes. The
notes will be issued in denominations of $1,000 and whole multiples of $1,000.
INTEREST
Lehman Brothers Holdings will pay interest semi-annually at a rate of 0.25% per
year to the person in whose name the note is registered at the close of business
on the first day of the month in which the interest payment is made. Lehman
Brothers Holdings will pay interest on the notes on May 14 and November 14 of
each
S-9
<PAGE>
year, beginning May 14, 2001. Interest on the notes will be calculated on the
basis of a 360-day year of twelve 30-day months. Additionally, if and to the
extent that the amount received on the stated maturity date or upon earlier
redemption, repurchase or sale exceeds $1,000 per $1,000 note, this amount will
be treated as a payment of interest rather than a capital gain under U.S.
Treasury regulations.
PAYMENT ON THE STATED MATURITY DATE
The notes will mature on November 14, 2007 unless postponed because a market
disruption event occurs; see "--Determination of alternative redemption amount"
below. Unless your notes have been previously redeemed by Lehman Brothers
Holdings or you instruct Lehman Brothers Holdings to repurchase the notes, you
will be entitled to receive per $1,000 note, on the stated maturity date, the
greater of:
o $1,000, plus accrued but unpaid interest; and
o the alternative redemption amount, as described below, plus accrued but
unpaid interest.
If the alternative redemption amount per $1,000 note is less than or equal to
$1,000, because the repayment of your principal amount is protected, you will be
entitled to receive $1,000, plus accrued but unpaid interest, per $1,000 note on
the stated maturity date.
EARLY REDEMPTION OF THE NOTES AT THE OPTION OF LEHMAN BROTHERS HOLDINGS
On or after November 9, 2002, Lehman Brothers Holdings may redeem all or part of
the notes on one or more occasions, at a redemption price per $1,000 note equal
to the greater of:
o $1,000, plus accrued but unpaid interest; and
o the alternative redemption amount, calculated as of the third business day
before the redemption date, plus accrued but unpaid interest.
If the alternative redemption amount per $1,000 note is less than or equal to
$1,000, because the repayment of your principal amount is protected, you will be
entitled to receive $1,000, plus accrued but unpaid interest per $1,000 note
upon redemption.
Citibank, N.A., the trustee for the notes, will give you at least 30 days'
notice of any redemption.
YOUR OPTION TO REQUIRE LEHMAN BROTHERS HOLDINGS TO REPURCHASE THE NOTES PRIOR TO
MATURITY
At any time until eight business days before November 9, 2007, you may instruct
Lehman Brothers Holdings to repurchase all or part of your notes at a price per
$1,000 note equal to the alternative redemption amount, calculated based on the
settlement value on the third business day before the repurchase date, plus
accrued but unpaid interest, by giving Lehman Brothers Holdings notice on any
business day at the corporate trust office of Citibank, N.A., the trustee for
the notes. The repurchase date will be the eighth business day following the
business day when Lehman Brothers Holdings receives a notice from you that
Lehman Brothers Holdings must repurchase your notes, unless payment is postponed
because a market disruption event occurs. See "--Determination of alternative
redemption amount" below.
If Lehman Brothers Holdings repurchases your notes, the amount you receive per
$1,000 note may be greater or less than $1,000.
Your election to require Lehman Brothers Holdings to repurchase a note will be
irrevocable. All questions as to the validity, eligibility, including time of
receipt, and acceptance of any note for repurchase will be determined by Lehman
Brothers Holdings, whose determination will be final and binding.
DETERMINATION OF ALTERNATIVE REDEMPTION AMOUNT
The alternative redemption amount per $1,000 note will be determined by the
calculation agent by the following formula:
$1,000
-------- x the settlement value
$52.3790
This formula accounts for the fact that the settlement value, on the stated
maturity date, must be greater than $52.3790 for you to receive any amount above
the principal amount of $1,000 per $1,000 note and the portion of any increase
you will receive if the settlement value is greater than $52.3790. $52.3790
represents 114.40% of $45.7858, which is the average execution price for Pfizer
common stock that an affiliate of Lehman Brothers Holdings paid to hedge Lehman
Brothers Holdings' obligations under the notes.
SETTLEMENT VALUE
The settlement value on the stated maturity date or upon redemption or
repurchase, as the case may be, will be determined by the calculation agent and
will be based on
S-10
<PAGE>
the closing prices of Pfizer common stock and/or other equity securities
received for Pfizer common stock or other equity securities included in the
calculation of the settlement value, on the third business day prior to the
stated maturity date, the redemption date or the repurchase date, as the case
may be. The settlement value will also include any cash received by a holder of
Pfizer common stock or those other equity securities as a result of
extraordinary corporate transactions involving their issuers. See "--Adjustments
to securities included in the calculation of the settlement value" below.
However, if the calculation agent determines that one or more market disruption
events have occurred on that day with respect to Pfizer common stock or other
equity securities included in the calculation of the settlement value, the
calculation agent will determine the closing price of those affected stocks or
securities on the next business day on which there is not a market disruption
event for it. This situation will cause the payment you receive to be postponed
until three business days after the date that the closing price of the affected
common stock or other equity security is determined.
"Closing price" means the last reported sales price on the relevant exchange,
trading system or market at 4:00 p.m., New York City time. If, however, Pfizer
common stock or any other equity securities included in the calculation of the
settlement value are listed or traded on a bulletin board at the time the
alternative redemption amount is determined, then the closing price of the
Pfizer common stock or that other equity security will be determined using the
average execution price that an affiliate of Lehman Brothers Holdings receives
upon the sale of Pfizer common stock or that other equity security used to hedge
Lehman Brothers Holdings' obligations under the notes.
You may call Lehman Brothers Inc. at 212-526-0900 to obtain the settlement value
and the number of shares of Pfizer common stock and other equity securities
included in the calculation of the settlement value per $1,000 note. Pfizer
common stock is listed on the New York Stock Exchange under the symbol "PFE."
ADJUSTMENTS TO SECURITIES INCLUDED IN THE CALCULATION OF THE SETTLEMENT VALUE
Adjustments to securities included in the calculation of the settlement value
will be made by adjusting the multiplier then in effect for the securities, by
adding new securities or cash and/or by removing current securities in the
circumstances described below. The multiplier for Pfizer common stock and any
other equity security included in the calculation of the settlement value will
represent the number of those securities included in the calculation of the
settlement value. Initially the multiplier for the Pfizer common stock will be
1.0. For purposes of these adjustments, except as noted below, ADRs are treated
like common stock if a comparable adjustment to the foreign shares underlying
the ADRs is made pursuant to the terms of the depositary arrangement for the
ADRs or if holders of ADRs are entitled to receive property in respect of the
underlying foreign share.
o If a common stock is subject to a stock split or reverse stock split, then
once the split has become effective, the multiplier relating to that common
stock will be adjusted. The multiplier will be adjusted to equal the
product of the number of shares outstanding after the split with respect to
each share immediately prior to effectiveness of the split and the prior
multiplier.
o If a common stock is subject to an extraordinary stock dividend or
extraordinary stock distribution in common stock that is given equally to
all holders of shares, then once the common stock is trading ex-dividend,
the multiplier will be increased by the product of the number of shares
issued with respect to one share and the prior multiplier.
o If the issuer of a common stock, or if a common stock is an ADR, the
foreign issuer of the underlying foreign share, is being liquidated or
dissolved or is subject to a proceeding under any applicable bankruptcy,
insolvency or other similar law, the common stock will continue to be
included in the calculation of the settlement value so long as the primary
exchange, trading system or market is reporting a market price for the
common stock. If a market price, including a price on a bulletin board
service, is no longer available for a common stock included in the
calculation of the settlement value, then the value of that common stock
will equal zero for so long as no market price is available, and no attempt
will be made to find a replacement stock or increase the settlement value
to compensate for the deletion of that common stock.
o If the issuer of a common stock, or if a common stock is an ADR, the
foreign issuer of the underlying foreign share, has been subject to a
merger or consolidation and is not the surviving entity and holders of the
common stock are entitled to receive cash, securities, other property or a
combination of those in exchange for the common stock, then the following
will be included in the settlement value:
-- To the extent cash is received, the settlement value will include the
amount of the cash consideration at the time holders are entitled to
S-11
<PAGE>
receive the cash consideration, plus accrued interest. Interest will
accrue beginning on the first London business day after the day on
which holders receive the cash consideration until the stated maturity
date. Interest will accrue at a rate equal to LIBOR with a term
corresponding to the interest accrual period stated in the preceding
sentence.
-- To the extent that equity securities that are traded or listed on an
exchange, trading system or market are received, once the exchange for
the new securities has become effective, the former common stock will
be removed from the calculation of the settlement value and the new
securities will be added to the calculation of the settlement value.
The multiplier for the new securities will equal the product of the
last value of the multiplier of the original underlying common stock
and the number of securities of the new security exchanged with
respect to one share of the original common stock.
-- To the extent that equity securities that are not traded or listed on
an exchange, trading system or market or non-equity securities or
other property (other than cash) is received, the calculation agent
will determine the fair market value of the securities or other
property received and the settlement value will include an amount of
cash equal to the product of the multiplier and the fair market value.
The settlement value will also include accrued interest on that
amount. Interest will accrue beginning on the first London business
day after the day that an affiliate of Lehman Brothers Holdings sells
the securities or other property used to hedge Lehman Brothers
Holdings' obligations under the notes until the stated maturity date.
Interest will accrue at a rate equal to LIBOR with a term
corresponding to the interest accrual period stated in the preceding
sentence.
o If all of the shares of a common stock are converted into or exchanged for
the same or a different number of shares of any class or classes of common
stock other than that common stock included in the calculation of the
settlement value, whether by capital reorganization, recapitalization or
reclassification, then, once the conversion has become effective, the
former common stock will be removed from the calculation of the settlement
value and the new common stock will be added to the calculation of the
settlement value. The multiplier for each new common stock added to the
settlement value will equal the product of the last value of the multiplier
of the original common stock and the number of shares of the new common
stock issued with respect to one share of the original common stock.
o If the issuer of a common stock, or if a common stock is an ADR, the issuer
of the underlying foreign share, issues to all of its shareholders common
stock or another equity security that is traded or listed on an exchange,
trading system or market of an issuer other than itself, then the new
common stock or other equity security will be added to the calculation of
the settlement value. The multiplier for the new common stock or other
equity security will equal the product of the last value of the multiplier
with respect to the original common stock and the number of shares of the
new common stock or other equity security issued with respect to one share
of the original common stock.
o If an ADR is no longer listed or admitted to trading on a United States
securities exchange registered under the Securities Exchange Act of 1934 or
is no longer a security quoted on the Nasdaq Stock Market, then the foreign
share underlying the ADR will be deemed to be a new common stock included
in the calculation of the settlement value. The initial multiplier for that
new underlying common stock will equal the last value of the multiplier for
the ADR multiplied by the number of underlying foreign shares represented
by a single ADR.
o If a common stock is subject to an extraordinary dividend or an
extraordinary distribution (including upon liquidation or dissolution) of
cash, equity securities that are not traded or listed on an exchange,
trading system or market, non-equity securities or other property of any
kind which is received equally by all holders of its common stock, then the
settlement value will include the following:
-- To the extent cash is entitled to be received, the settlement value
will include on each day after the time that the common stock trades
ex-dividend until the date the cash consideration is entitled to be
received, the present value of the cash to be received, discounted at
a rate equal to LIBOR, with a term beginning that day and ending on
the date that the cash is entitled to be received. When the cash
consideration is received, the settlement value will include the
amount of the cash consideration, plus accrued interest. Interest will
accrue beginning the first London business day after the day that
holders receive the cash consideration until the stated
S-12
<PAGE>
maturity date. Interest will accrue at a rate equal to LIBOR with a
term corresponding to the interest accrual period stated in the
preceding sentence.
-- To the extent that equity securities that are not traded or listed on
an exchange, trading system or market or non-equity securities or
other property (other than cash) are received, the calculation agent
will determine the fair market value of the securities or other
property received and the calculation of the settlement value will
include an amount of cash equal to the product of the multiplier and
the fair market value. The settlement value will also include accrued
interest on that amount. Interest will accrue beginning on the first
London business day after the day that an affiliate of Lehman Brothers
Holdings sells the securities or other property used to hedge Lehman
Brothers Holdings' obligations under the notes until the stated
maturity date. Interest will accrue at a rate equal to LIBOR with a
term corresponding to the interest accrual period stated in the
preceding sentence.
o If similar corporate events occur with respect to the issuer of an equity
security other than common stock that is included in the calculation of the
settlement value, adjustments similar to the above will be made for that
equity security. In addition, if any other corporate events occur with
respect to the issuer or a common stock or other equity security included
in the calculation of the settlement value, adjustments will be made to
reflect the economic substance of those events.
The payment of an ordinary cash dividend from current income or retained
earnings will not result in an adjustment to the multiplier or entitle you to
any cash payments.
No adjustments of any multiplier of a common stock will be required unless the
adjustment would require a change of at least .1% (.001) in the multiplier then
in effect. The multiplier resulting from any of the adjustments specified above
will be rounded at the calculation agent's discretion.
MARKET DISRUPTION EVENTS
A market disruption event with respect to Pfizer common stock or other equity
security included in the calculation of the settlement value will occur on any
day if the calculation agent determines that:
o A suspension, absence or material limitation of trading in the Pfizer
common stock or that other equity security has occurred on that day, in
each case, for more than two hours of trading or during the one-half hour
period preceding the close of trading on the primary organized U.S.
exchange or trading system on which that security is traded or, if Pfizer
common stock or that other equity security is not listed or quoted in the
United States, on the primary exchange, trading system or market for that
security. Limitations on trading during significant market fluctuations
imposed pursuant to New York Stock Exchange Rule 80B or any applicable rule
or regulation enacted or promulgated by the New York Stock Exchange, any
other exchange, trading system or market, any other self regulatory
organization or the SEC of similar scope or as a replacement for Rule 80B
may be considered material. For purposes of this prospectus supplement,
"trading system" includes bulletin board services. Notwithstanding the
first sentence of this paragraph, a market disruption event for a security
traded on a bulletin board means a suspension, absence or material
limitation of trading of that security for more than two hours or during
the one hour period preceding 4:00 p.m., New York City time.
o A suspension, absence or material limitation has occurred on that day, in
each case, for more than two hours of trading or during the one-half hour
period preceding the close of trading in options contracts related to
Pfizer common stock or that other equity security, whether by reason of
movements in price exceeding levels permitted by an exchange, trading
system or market on which those options contracts are traded or otherwise.
o Information is unavailable on that date, through a recognized system of
public dissemination of transaction information, for more than two hours of
trading or during the one-half hour period preceding the close of trading,
of accurate price, volume or related information in respect of Pfizer
common stock or that other equity security or in respect of options
contracts related to Pfizer common stock or that other equity security, in
each case traded on any major U.S. exchange or trading system or, in the
case of securities of a non-U.S. issuer, traded on the primary non-U.S.
exchange, trading system or market.
For purposes of determining whether a market disruption event has occurred:
S-13
<PAGE>
o a limitation on the hours or number of days of trading will not constitute
a market disruption event if it results from an announced change in the
regular business hours of the relevant exchange, trading system or market;
o any suspension in trading in an option contract on the Pfizer common stock
or that other equity security by a major securities exchange, trading
system or market by reason of:
-- a price change violating limits set by that securities market,
-- an imbalance of orders relating to those contracts or
-- a disparity in bid and ask quotes relating to those contracts,
will constitute a market disruption event notwithstanding that the
suspension or material limitation is less than two hours;
o a suspension or material limitation on an exchange, trading system or in a
market will include a suspension or material limitation of trading by one
class of investors provided that the suspension continues for more than two
hours of trading or during the last one-half hour period preceding the
close of trading on the relevant exchange, trading system or market but
will not include any time when the relevant exchange, trading system or
market is closed for trading as part of that exchange's, trading system's
or market's regularly scheduled business hours; and
o "close of trading" means 4:00 p.m., New York City time.
Under certain circumstances, the duties of Lehman Brothers Inc. as the
calculation agent in determining the existence of market disruption events could
conflict with the interests of Lehman Brothers Inc. as an affiliate of the
issuer of the notes.
Based on the information currently available to Lehman Brothers Holdings, on
October 27, 1997, the New York Stock Exchange suspended all trading during the
one-half hour period preceding the close of trading pursuant to New York Stock
Exchange Rule 80B. On April 3, 1992, no trading took place on the Chicago
Mercantile Exchange, because a flood that severely affected the operations of
many of the CME's member institutions caused the CME to suspend trading for the
entire day. On August 12, 1999, the Chicago Board of Trade suspended all trading
after 2 p.m., New York City time, because a power failure in the Chicago
downtown area caused the CBT to close an hour early. The same power failure also
caused the Chicago Board Options Exchange to halt trading for a one-half hour
period on August 12, 1999. On September 16, 1999, stormy weather from Hurricane
Floyd led the New York Mercantile and Commodity Exchange and the New York Board
of Trade to close early at noon and 1:00 p.m., respectively, New York City time.
If any suspension of trading caused by similar events occurs during the term of
the notes, that event could constitute a market disruption event. The existence
or non-existence of such circumstances, however, is not necessarily indicative
of the likelihood of those circumstances arising or not arising in the future.
HYPOTHETICAL RETURNS
The table on the next page illustrates, for a range of hypothetical settlement
values three days prior to the stated maturity date:
o the hypothetical settlement values per $1,000 note;
o the hypothetical alternative redemption amount per $1,000 note;
o the percentage change from the principal amount to the hypothetical
alternative redemption amount per $1,000 note;
o the hypothetical total amount payable per $1,000 note;
o the hypothetical total rate of return per $1,000 note without interest;
o the hypothetical pre-tax annualized rate of return per $1,000 note without
interest;
o the hypothetical total rate of return per $1,000 note including interest;
and
o the hypothetical pre-tax annualized rate of return per $1,000 note
including interest.
S-14
<PAGE>
<TABLE>
<CAPTION>
TOTAL
PERCENTAGE AMOUNT ANNUALIZED
CHANGE OF PAYABLE AT PRE-TAX ANNUALIZED
ALTERNATIVE STATED TOTAL RATE RATE OF PRE-
HYPOTHETICAL REDEMPTION MATURITY OF RETURN TOTAL RATE OF TAX RATE OF
HYPOTHETICAL ALTERNATIVE AMOUNT OVER PER RETURN PER PER $1,000 RETURN PER RETURN PER
SETTLEMENT REDEMPTION THE PRINCIPAL $1,000 NOTE $1,000 NOTE NOTE $1,000 NOTE $1,000 NOTE
VALUE PER AMOUNT PER AMOUNT PER WITHOUT WITHOUT WITHOUT WITH WITH
$1,000 NOTE $1,000 NOTE $1,000 NOTE INTEREST INTEREST INTEREST INTEREST INTEREST
----------- ----------- ----------- -------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C> <C> <C>
$ 40 $ 763.66 -23.63% $ 1,000 0.00% 0.00% 1.75% 0.25%
$ 45 $ 859.12 -14.09% $ 1,000 0.00% 0.00% 1.75% 0.25%
$ 50 $ 954.58 -4.54% $ 1,000 0.00% 0.00% 1.75% 0.25%
$ 52.3790 $ 1,000.00 0.00% $ 1,000 0.00% 0.00% 1.75% 0.25%
$ 70 $ 1,336.41 33.64% $ 1,336.41 33.64% 4.23% 35.39% 4.42%
$ 100 $ 1,909.16 90.92% $ 1,909.16 90.92% 9.68% 92.67% 9.82%
$ 150 $ 2,863.74 186.37% $ 2,863.74 186.37% 16.22% 188.12% 16.32%
$ 200 $ 3,818.32 281.83% $ 3,818.32 281.83% 21.09% 283.58% 21.18%
$ 300 $ 5,727.49 472.75% $ 5,727.49 472.75% 28.32% 474.50% 28.38%
$ 500 $ 9,545.81 854.58% $ 9,545.81 854.58% 38.03% 856.33% 38.07%
</TABLE>
The above figures are for purposes of illustration only. The actual amount
received by investors and the resulting total and pre-tax rate of return will
depend entirely on the actual settlement value and the alternative redemption
amount determined by the calculation agent. In particular, the actual settlement
value could be lower or higher than those reflected in the table.
You should compare the features of the notes to other available investments
before deciding to purchase the notes. Due to the uncertainty as to whether the
alternative redemption amount, at stated maturity or in connection with a
repurchase or redemption, will be greater than $1,000 per $1,000 note or the
notes will be redeemed prior to the stated maturity date, the return on
investment with respect to the notes may be higher or lower than the return
available on other securities issued by Lehman Brothers Holdings or by others
and available through Lehman Brothers Inc. You should reach an investment
decision only after carefully considering the suitability of the notes in light
of your particular circumstances.
CALCULATION AGENT
Lehman Brothers Inc., a subsidiary of Lehman Brothers Holdings, will act as
calculation agent for the notes.
The calculation agent will determine the amount you receive at the stated
maturity of the notes or upon their earlier redemption or repurchase by Lehman
Brothers Holdings. In each case the calculation agent will determine the
alternative redemption amount and, in the case of the stated maturity or
redemption of the notes, whether you will receive the alternative redemption
amount or $1,000 per $1,000 note, plus accrued and unpaid interest.
In addition, the calculation agent will determine:
o if adjustments are required to securities included in the calculation of
the settlement value under various circumstances; see "--Adjustments to
securities included in the calculation of the settlement value" on page
S-11;
o whether a market disruption event has occurred; see "--Market disruption
events" on page S-13;
o for any foreign currency or foreign common stock or other equity security
received if an event occurs as described in "-Adjustments to securities
included in the calculation of the settlement value" beginning on page
S-11, the applicable foreign exchange conversion rate using the appropriate
official W.M. Reuters spot closing rate at 11:00 a.m., New York City time,
if available, to convert non-U.S. traded securities prices or non-U.S.
dollar denominated cash from the respective country's currency to U.S.
dollars. If there are several quotes at that time, the first quoted rate in
that minute will be used. In the event there is no such exchange rate for a
country's currency at 11:00 a.m., New York City time, securities will be
valued at the last available dollar cross-rate quote before 11:00 a.m., New
York City time;
o for Pfizer common stock or another equity security that is listed or quoted
on a bulletin board service, the value of Pfizer common stock or that other
equity security using the average execution price that an affiliate of
Lehman Brothers Holdings receives upon a sale of Pfizer common stock or
that other equity security used to hedge Lehman Brothers Holdings'
obligations under the notes; and
o for an equity security that is not traded or listed on an exchange, trading
system or market or a non-equity
S-15
<PAGE>
security or other property (other than cash), if an event occurs as
described in "--Adjustments to securities included in the calculation of
the settlement value" beginning on page S-11, as soon as reasonably
practicable after the date the property or security is received, the fair
market value of that property or security based on the average execution
price that an affiliate of Lehman Brothers Holdings receives upon a sale of
that property or security used to hedge Lehman Brothers Holdings'
obligations under the notes.
All determinations made by the calculation agent will be at the sole discretion
of the calculation agent and, in the absence of manifest error, will be
conclusive for all purposes and binding on Lehman Brothers Holdings and you. The
calculation agent will have no liability for its determinations.
Lehman Brothers Holdings or its affiliates, including Lehman Brothers Inc., may
from time to time engage in business with one or more of Pfizer or the issuers
of other equity securities included in the calculation of the settlement value
or, in the case of ADRs, the underlying foreign shares, or with persons seeking
to acquire Pfizer or these other issuers. The services provided may include
advisory services to the issuers or other persons, including merger and
acquisition advisory services. In the course of its business, Lehman Brothers
Holdings or its affiliates, including Lehman Brothers Inc., may acquire
non-public information with respect to Pfizer or these other issuers. In
addition, one or more affiliates of Lehman Brothers Holdings may publish
research reports with respect to Pfizer or these other issuers. The actions may
directly adversely affect the market prices of Pfizer common stock or the other
equity securities.
EVENTS OF DEFAULT AND ACCELERATION
If an event of default with respect to any notes has occurred and is continuing,
the amount payable to you upon any acceleration permitted under the senior
indenture will be equal to, per $1,000 note, the greater of $1,000 or the
alternative redemption amount, in each case plus accrued but unpaid interest,
calculated as though the date of acceleration was the stated maturity date and
the date three business days before the date of acceleration was the valuation
date. If a bankruptcy proceeding is commenced in respect of Lehman Brothers
Holdings, the claims of the holder of a note may be limited, under Section
502(b)(2) of Title 11 of the United States Code, as though the commencement of
the proceeding was the stated maturity.
S-16
<PAGE>
PFIZER COMMON STOCK
PFIZER
Pfizer is a research-based global pharmaceutical company which discovers,
develops, manufactures and markets innovative medicines for humans and animals.
Pfizer operates in two business segments:
o pharmaceutical, which includes its human pharmaceutical, animal health
and capsule businesses; and
o consumer products, which includes its consumer healthcare products,
confectionery products, shaving products and its ornamental fish food
and fish care products.
The Pfizer common stock is registered under the Securities Exchange Act of 1934.
Companies with securities registered under that Act are required to file
periodically certain financial and other information specified by the Securities
and Exchange Commission. Information provided to or filed with the SEC can be
inspected and copied at the public reference facilities maintained by the SEC or
through the SEC's website described under "Available Information" on page 2 of
the accompanying prospectus. In addition, information regarding Pfizer may be
obtained from other sources including, but not limited to, press releases,
newspaper articles and other publicly disseminated documents. We make no
representation or warranty as to the accuracy or completeness of those reports.
HISTORICAL INFORMATION ABOUT THE PFIZER COMMON STOCK
The Pfizer common stock is listed on the New York Stock Exchange under the
symbol "PFE."
The following table presents the high and low closing prices for the Pfizer
common stock as reported on the New York Stock Exchange during 1995, 1996, 1997,
1998 and 1999 and during 2000 (through November 8, 2000), and the closing price
on December 31, 1995, 1996, 1997, 1998 and 1999 and on November 8, 2000. All
values in the table are set forth in U.S. dollars. These prices are not
indications of future performance. We cannot assure you that the prices of the
Pfizer common stock will increase enough so that the alternative redemption
amount will be greater than $1,000. The historical prices below have been
adjusted to reflect the two-for-one stock split effective July 3, 1995, the
two-for-one stock split effective July 1, 1997 and the three-for-one stock split
effective July 1, 1999.
<TABLE>
<CAPTION>
HIGH PRICE LOW PRICE CLOSING PRICE
DURING PERIOD DURING PERIOD AT PERIOD END
----------------------------------------------------------
<S> <C> <C> <C>
1995
First Quarter.................................... $ 7.457 $ 6.219 $ 7.145
Second Quarter................................... 7.832 6.770 7.676
Third Quarter.................................... 8.957 7.313 8.895
Fourth Quarter................................... 11.043 8.875 10.500
1996
First Quarter.................................... $11.707 $10.125 $11.207
Second Quarter................................... 12.625 10.770 11.895
Third Quarter.................................... 13.188 11.645 13.188
Fourth Quarter................................... 15.082 13.125 13.832
1997
First Quarter.................................... $16.457 $13.645 $14.020
Second Quarter................................... 20.332 13.895 19.918
Third Quarter.................................... 21.250 17.480 20.043
Fourth Quarter................................... 25.938 20.082 24.855
1998
First Quarter.................................... $33.230 $24.645 $33.230
Second Quarter................................... 39.418 32.520 36.230
Third Quarter.................................... 39.563 31.000 35.250
Fourth Quarter................................... 42.105 29.168 41.668
S-17
<PAGE>
<CAPTION>
HIGH PRICE LOW PRICE CLOSING PRICE
DURING PERIOD DURING PERIOD AT PERIOD END
----------------------------------------------------------
<S> <C> <C> <C>
1999
First Quarter.................................... $47.688 $38.582 $46.250
Second Quarter................................... 50.043 31.707 36.332
Third Quarter.................................... 40.375 32.750 35.875
Fourth Quarter................................... 41.750 32.438 32.438
2000
First Quarter.................................... $37.813 $30.000 $36.563
Second Quarter................................... 48.000 37.938 48.000
Third Quarter.................................... 49.000 39.875 44.918
Fourth Quarter (through November 8, 2000) ....... 45.375 42.625 45.375
</TABLE>
UNITED STATES FEDERAL
INCOME TAX CONSEQUENCES
The following is a summary of the material United States federal income tax
consequences of the purchase, ownership, and disposition of notes as of the date
of this prospectus supplement. Except where noted, this summary deals only with
a note held as a capital asset by a United States holder who purchases the note
on original issue at its initial offering price, and it does not deal with
special situations. For example, this summary does not address:
o tax consequences to holders who may be subject to special tax treatment,
such as dealers in securities or currencies, traders in securities that
elect to use the mark-to-market method of accounting for their securities,
financial institutions, regulated investment companies, real estate
investment trusts, tax-exempt entities or life insurance companies;
o tax consequences to persons holding notes as part of a hedging, integrated,
constructive sale or conversion transaction or a straddle;
o tax consequences to holders of notes whose "functional currency" is not the
U.S. dollar;
o alternative minimum tax consequences, if any; or
o any state, local or foreign tax consequences.
The discussion below is based upon the provisions of the Internal Revenue Code
of 1986, as amended (which we refer to as the Code), and regulations, rulings
and judicial decisions as of the date of this prospectus supplement. Those
authorities may be changed, perhaps retroactively, so as to result in United
States federal income tax consequences different from those discussed below.
If a partnership holds the notes, the tax treatment of a partner will generally
depend upon the status of the partner and the activities of the partnership. If
you are a partner of a partnership holding the notes, you should consult your
own tax advisors.
If you are considering the purchase of notes, you should consult your own tax
advisors concerning the federal income tax consequences in light of your
particular situation and any consequences arising under the laws of any other
taxing jurisdiction.
UNITED STATES HOLDERS
The following discussion is a summary of certain United States federal tax
consequences that will apply to you if you are a United States holder of notes.
For purposes of this discussion, a United States holder is the beneficial owner
of a note that is:
o a citizen or resident of the United States;
o a corporation or partnership created or organized in or under the laws of
the United States or any political subdivision of the United States;
o an estate the income of which is subject to United States federal income
taxation regardless of its source; or
o a trust (1) that is subject to the supervision of a court within the United
States and the control of one or more United States persons as defined in
Section 7701(a)(30) of the Code or (2) that has a valid election in effect
under applicable Treasury regulations to be treated as a United States
person.
ACCRUAL OF INTEREST
The Treasury regulations that apply to contingent payment debt obligations will
apply to the notes. All payments on the notes including stated interest will be
S-18
<PAGE>
taken into account under these Treasury regulations and actual cash payments of
interest on the notes will not be reported separately as taxable income. As
discussed more fully below, the effect of these Treasury regulations will be to:
o require you, regardless of your usual method of tax accounting, to use the
accrual method with respect to the notes;
o result in the accrual of original issue discount by you in excess of stated
interest payments actually received by you; and
o generally result in ordinary rather than capital treatment of any gain, and
to some extent loss, on the sale, exchange, repurchase or redemption of the
notes.
Under the contingent payment debt rules, you will be required to include
original issue discount in income each year, regardless of your usual method of
tax accounting, based on the "comparable yield" of the notes, which will
generally be the rate at which Lehman Brothers Holdings could issue a fixed rate
debt instrument with terms and conditions similar to the notes.
Lehman Brothers Holdings is required to provide the comparable yield to you and,
solely for tax purposes, is also required to provide a projected payment
schedule that includes the actual interest payments on the notes and estimates
the amount and timing of contingent payments on the notes. Lehman Brothers
Holdings has determined that the comparable yield is an annual rate of 7.75%,
compounded semi-annually. Based on the comparable yield, the projected payment
schedule per $1000 note is $1.25 due semi-annually and $1,681.35 paid on the
stated maturity date which includes the final interest payment.
THE COMPARABLE YIELD AND THE PROJECTED PAYMENT SCHEDULE ARE NOT PROVIDED FOR ANY
PURPOSE OTHER THAN THE DETERMINATION OF YOUR INTEREST ACCRUALS AND ADJUSTMENTS
THEREOF IN RESPECT OF THE NOTES AND DO NOT CONSTITUTE A REPRESENTATION REGARDING
THE ACTUAL AMOUNT OF THE PAYMENTS ON A NOTE.
The amount of original issue discount on a note for each accrual period is then
determined by multiplying the comparable yield of the note, adjusted for the
length of the accrual period, by the note's adjusted issue price at the
beginning of the accrual period, determined in accordance with the rules set
forth in the contingent payment debt rules. The amount of original issue
discount so determined is then allocated on a ratable basis to each day in the
accrual period that you held the note. Lehman Brothers Holdings is required to
provide information returns stating the amount of original issue discount
accrued on notes held of record by persons other than corporations and other
exempt owners.
If an actual contingent payment made on the notes differs from the projected
contingent payment, an adjustment will be made for the difference. A positive
adjustment, for the amount by which an actual payment exceeds the projected
contingent payment, will be treated as additional original issue discount in the
current year. A negative adjustment will:
o first, reduce the amount of original issue discount required to be accrued
in the current year; and
o second, any negative adjustments that exceed the amount of original issue
discount accrued in the current year will be treated as ordinary loss to
the extent of your total prior original issue discount inclusions with
respect to the note.
You are generally bound by the above comparable yield and projected payment
schedule. However, if you believe that Lehman Brothers Holdings' projected
payment schedule is unreasonable, you may set your own projected payment
schedule so long as you explicitly disclose the use of, and the reason for, that
schedule. Unless otherwise prescribed by the Commissioner of the Internal
Revenue Service, that disclosure must be made in a statement attached to your
timely filed federal income tax return for the taxable year in which a note is
acquired.
SALE, EXCHANGE OR OTHER DISPOSITION OF NOTES
Upon the sale, exchange, repurchase or redemption of a note, you will recognize
gain or loss equal to the difference between your amount realized and your
adjusted tax basis in the note. Such gain on a note generally will be treated as
ordinary income. Loss from the disposition of a note will be treated as ordinary
loss to the extent of your prior net original issue discount inclusions with
respect to the note.
Special rules apply in determining the tax basis of a note. Your basis in a note
is generally increased by original issue discount you previously accrued on the
note, and reduced by the projected amount of any payments previously scheduled
to be made.
NON-UNITED STATES HOLDERS
The following discussion is a summary of certain United States federal tax
consequences that will apply to you if you are a Non-United States holder of
notes. Special rules may apply to you if you are a controlled foreign
corporation, passive foreign investment company or foreign personal holding
company and therefore subject
S-19
<PAGE>
to special treatment under the Code. You should consult your own tax advisors to
determine the U.S. federal, state, local and other tax consequences that may be
relevant to you.
UNITED STATES FEDERAL WITHHOLDING TAX
The 30% U.S. federal withholding tax will not apply to any payment of principal
and interest, including original issue discount, on redemption of a note
provided that:
o you do not actually, or constructively, own 10% or more of the total
combined voting power of all classes of Lehman Brothers Holdings' voting
stock within the meaning of the Code and the Treasury regulations;
o you are not a controlled foreign corporation that is related to Lehman
Brothers Holdings through stock ownership;
o you are not a bank whose receipt of interest on a note is described in
Section 881(c)(3)(A) of the Code; and
o (1) you provide your name and address on an IRS Form W-8BEN and certify,
under penalty of perjury, that you are not a United States holder or (2)
you hold your notes through certain foreign intermediaries or foreign
partnerships and you satisfy the certification requirements of applicable
Treasury regulations.
For payments made on or before December 31, 2000, the certification requirements
described in the fourth bullet point above differ slightly under current
Treasury regulations that expire on December 31, 2000. If you cannot satisfy the
requirements described above, payments of principal and interest, including
original issue discount, made to you will be subject to the 30% U.S. federal
withholding tax, unless you provide Lehman Brothers Holdings with a properly
executed (1) IRS Form W-8BEN claiming an exemption from, or reduction in,
withholding under the benefit of a tax treaty or (2) IRS Form W-8ECI stating
that interest paid on a note is not subject to withholding tax because it is
effectively connected with your conduct of a trade or business in the United
States.
For gain or income that you realize on the sale, exchange or other disposition
of a note on or after January 1, 2001, Treasury regulations will require
withholding in certain circumstances unless the conditions described in the
fourth bullet point above are satisfied.
UNITED STATES FEDERAL INCOME TAX
Any original issue discount, gain or income on a note will generally be subject
to U.S. federal income tax if you are engaged in a trade or business in the
United States, and original issue discount, gain or income on the notes is
effectively connected with the conduct of that trade or business. In such case,
you will be subject to U.S. federal income tax on such original issue discount,
gain or income on a net income basis in the same manner as if you were a United
States holder. In addition, if you are a foreign corporation, you may be subject
to a branch profits tax equal to 30%, or lower applicable treaty rate, of your
earnings and profits for the taxable year, subject to adjustments, that are
effectively connected with the conduct by you of a trade or business in the
United States. For this purpose, effectively connected original issue discount,
gain and income on the notes will be included in earnings and profits.
UNITED STATES FEDERAL ESTATE TAX
Your estate will not be subject to U.S. federal estate tax on notes beneficially
owned by you at the time of your death, provided that (1) you do not own 10% or
more of the total combined voting power of all classes of Lehman Brothers
Holdings' voting stock, within the meaning of the Code and the Treasury
regulations, and (2) original issue discount on that note would not have been,
if received at the time of your death, effectively connected with the conduct by
you of a trade or business in the United States.
INFORMATION REPORTING AND BACKUP WITHHOLDING
If you are a United States holder of notes, information reporting requirements
will generally apply to all payments Lehman Brothers Holdings makes to you and
the proceeds from the sale of a note made to you, unless you are an exempt
recipient such as a corporation. A 31% backup withholding tax will apply to
those payments if you fail to provide a taxpayer identification number, a
certification of exempt status, or if you fail to report in full interest
income.
Under Treasury regulations that become effective for payments made after January
1, 2001, if you are a Non-United States holder of notes, you will not be
required to pay backup withholding and provide information reporting regarding
payments Lehman Brothers Holdings makes to you provided that Lehman Brothers
Holdings does not have actual knowledge that you are a United States holder and
Lehman Brothers Holdings has received from you the statement described above
under "Non-United States Holders-U.S. Federal Withholding Tax." In addition, you
will not be required to pay backup withholding and provide information reporting
regarding the proceeds of the sale of a note within the United States or
conducted through certain U.S.-related financial intermediaries, if the payor
receives the statement
S-20
<PAGE>
described above and does not have actual knowledge that you are a United States
holder, or you otherwise establish an exemption.
For payments made on or before December 31, 2000, the information and backup
withholding rules discussed above differ slightly under current Treasury
regulations that expire on December 31, 2000.
Any amounts withheld under the backup withholding rules will be allowed as a
refund or credit against your U.S. federal income tax liability provided the
required information is furnished to the Internal Revenue Service.
BOOK-ENTRY ISSUANCE
The notes will be represented by one or more global securities that will be
deposited with and registered in the name of DTC or its nominee. This means that
Lehman Brothers Holdings will not issue certificates to you for the notes. Each
global security will be issued to DTC which will keep a computerized record of
its participants (for example, a broker) whose clients have purchased the notes.
Each participant will then keep a record of its clients. Unless it is exchanged
in whole or in part for a certificated security, a global security may not be
transferred. However, DTC, its nominees and their successors may transfer a
global security as a whole to one another.
Beneficial interests in a global security will be shown on, and transfers of the
global security will be made only through, records maintained by DTC and its
participants. DTC holds securities that its direct participants deposit with
DTC. DTC also records the settlements among direct participants of securities
transactions, such as transfers and pledges, in deposited securities through
computerized records for direct participants' accounts. This eliminates the need
to exchange certificates. Direct participants include securities brokers and
dealers, banks, trust companies, clearing corporations and certain other
organizations. DTC's book-entry system is also used by other organizations such
as securities brokers and dealers, banks and trust companies that work through a
direct participant.
When you purchase notes through the DTC system, the purchases must be made by or
through a direct participant, who will receive credit for the notes on DTC's
records. Since you actually own the notes, you are the beneficial owner. Your
ownership interest will only be recorded on the direct or indirect participants'
records. DTC has no knowledge of your individual ownership of the notes. DTC's
records only show the identity of the direct participants and the amount of the
notes held by or through them. You will not receive a written confirmation of
your purchase or sale or any periodic account statement directly from DTC. You
should instead receive these from your direct or indirect participant. As a
result, the direct or indirect participants are responsible for keeping accurate
account of the holdings of their customers like you.
The trustee for the notes will wire payments on the notes to DTC's nominee.
Lehman Brothers Holdings and the trustee will treat DTC's nominee as the owner
of each global security for all purposes. Accordingly, Lehman Brothers Holdings,
the trustee and any paying agent will have no direct responsibility or liability
to pay amounts due on the global security to you or any other beneficial owners
in the global security. Any redemption notices will be sent by Lehman Brothers
Holdings directly to DTC, who will in turn inform the direct participants or the
indirect participants, who will then contact you as a beneficial holder. If less
than all of the notes are being redeemed, DTC will proportionally allot the
amount of the interest of each direct participant to be redeemed.
It is DTC's current practice, upon receipt of any payment of interest,
distributions or liquidation amount, to proportionally credit direct
participants' accounts on the payment date based on their holdings. In addition,
it is DTC's current practice to pass through any consenting or voting rights to
the participants by using an omnibus proxy. Those participants in turn will make
payments to and solicit votes from you, the ultimate owner of notes based on
customary practices. Payments to you will be the responsibility of the
participants and not of DTC, the trustee or Lehman Brothers Holdings.
Notes represented by a global security will be exchangeable for certificated
securities with the same terms in authorized denominations only if:
o DTC is unwilling or unable to continue as depositary or ceases to be a
clearing agency registered under applicable law and a successor is not
appointed by Lehman Brothers Holdings within 90 days; or
o Lehman Brothers Holdings decides to discontinue use of the book-entry
system.
If the global security is exchanged for certificated securities, the trustee
will keep the registration books for the notes at its corporate office and
follow customary practices and procedures.
S-21
<PAGE>
DTC has provided Lehman Brothers Holdings with the following information: DTC is
a limited-purpose trust company organized under the New York Banking Law, a
"banking organization" within the meaning of the New York Banking Law, a member
of the United States Federal Reserve System, a "clearing corporation" within the
meaning of the New York Uniform Commercial Code and a "clearing agency"
registered under the provisions of Section 17A of the Securities Exchange Act of
1934. DTC is owned by a number of its direct participants and by the New York
Stock Exchange, the American Stock Exchange and the National Association of
Securities Dealers, Inc. The rules that apply to DTC and its participants are on
file with the SEC.
CLEARSTREAM AND EUROCLEAR
Links have been established among DTC, Clearstream Banking and Euroclear (two
European book-entry depositories similar to DTC), to facilitate the initial
issuance of the notes and cross-market transfers of the notes associated with
secondary market trading.
Although DTC, Clearstream and Euroclear have agreed to the procedures provided
below in order to facilitate transfers, they are under no obligation to perform
those procedures and those procedures may be modified or discontinued at any
time.
Clearstream and Euroclear will record the ownership interests of their
participants in much the same way as DTC, and DTC will record the aggregate
ownership of each U.S. agent of Clearstream and Euroclear, as participants in
DTC.
When notes are to be transferred from the account of a DTC participant to the
account of a Clearstream participant or a Euroclear participant, the purchaser
must send instructions to Clearstream or Euroclear through a participant at
least one business day prior to settlement. Clearstream or Euroclear, as the
case may be, will instruct its U.S. agent to receive the notes against payment.
After settlement, Clearstream or Euroclear will credit its participant's
account. Credit for the notes will appear on the next day, European time.
Because the settlement is taking place during New York business hours, DTC
participants can employ their usual procedures for sending notes to the relevant
U.S. agent acting for the benefit of Clearstream or Euroclear participants. The
sale proceeds will be available to the DTC seller on the settlement date. Thus,
to the DTC participant, a cross-market transaction will settle no differently
than a trade between two DTC participants.
When a Clearstream or Euroclear participant wishes to transfer notes to a DTC
participant, the seller must send instructions to Clearstream or Euroclear
through a participant at least one business day prior to settlement. In these
cases, Clearstream or Euroclear will instruct its U.S. agent to transfer notes
against payment. The payment will then be reflected in the account of the
Clearstream or Euroclear participant the following day, with the proceeds
back-valued to the value date; which day would be the preceding day, when
settlement occurs in New York. If settlement is not completed on the intended
value date (I.E., the trade falls), proceeds credited to the Clearstream or
Euroclear participant's account would instead be valued as of the actual
settlement date.
UNDERWRITING
Lehman Brothers Holdings has agreed to sell to Lehman Brothers Inc., the
underwriter, all of the notes.
The underwriter has advised Lehman Brothers Holdings that it proposes to
initially offer the notes to the public at the public offering price indicated
on the cover page of this prospectus supplement. After the initial public
offering of the notes is completed, the public offering price and concessions
may be changed.
In connection with the offering, the rules of the SEC permit the underwriter to
engage in various transactions that stabilize the price of the notes. These
transactions may consist of bids or purchases for the purpose of pegging, fixing
or maintaining the price of the notes. If the underwriter creates a short
position in the notes in connection with the offering (that is, if it sells a
larger number of the notes than is indicated on the cover page of this
prospectus supplement), the underwriter may reduce that short position by
purchasing notes in the open market.
In general, purchases of a security for the purpose of stabilization or to
reduce a syndicate short position could cause the price of the security to be
higher than it might otherwise be in the absence of those purchases. Neither
Lehman Brothers Holdings nor the underwriter makes any representation or
prediction as to the direction or magnitude of any effect that the transactions
described above may have on the price of the notes. In addition, neither Lehman
Brothers Holdings nor the underwriter makes any representation that the
underwriter will in fact engage in transactions described in this paragraph, or
that those transactions, once begun, will not be discontinued without notice.
S-22
<PAGE>
Lehman Brothers Holdings will pay certain expenses, expected to be approximately
$60,000, associated with the offer and sale of the notes.
The underwriter may not confirm sales to any account over which it exercises
discretionary authority without the prior written approval of the customer.
Lehman Brothers Holdings has agreed to indemnify the underwriter against some
liabilities, including liabilities under the Securities Act of 1933.
The underwriting arrangements for this offering comply with the requirements of
Rule 2720 of the NASD regarding an NASD member firm underwriting securities of
its affiliate.
EXPERTS
The consolidated financial statements and financial statement schedule of Lehman
Brothers Holdings as of November 30, 1999 and 1998, and for each of the years in
the three-year period ended November 30, 1999, have been audited by Ernst &
Young LLP, independent certified public accountants, as set forth in their
report on the consolidated financial statements. The consolidated financial
statements and accountant's report are incorporated by reference in Lehman
Brothers Holdings' annual report on Form 10-K for the year ended November 30,
1999, and incorporated by reference in this prospectus supplement. The
consolidated financial statements of Lehman Brothers Holdings referred to above
are incorporated by reference in this prospectus supplement in reliance upon the
report given on the authority of Ernst & Young LLP as experts in accounting and
auditing.
S-23
<PAGE>
PROSPECTUS
LEHMAN BROTHERS HOLDINGS INC.
DEBT SECURITIES, DEBT WARRANTS, CURRENCY WARRANTS,
INDEX WARRANTS AND INTEREST RATE WARRANTS
----------------
Lehman Brothers Holdings Inc. ("Holdings") may offer from time to time (i)
unsecured debt securities (the "Debt Securities") consisting of debentures,
notes and/or other evidences of indebtedness, (ii) warrants to purchase Debt
Securities ("Debt Warrants"), (iii) warrants entitling the holders thereof to
receive from Holdings, upon exercise, the cash value of the right to purchase
("Currency Call Warrants") and to sell ("Currency Put Warrants" and, together
with the Currency Call Warrants, the "Currency Warrants") a certain amount of
one currency or currency unit for a certain amount of a different currency or
currency unit, all as shall be designated by Holdings at the time of offering,
(iv) warrants entitling the holders thereof to receive from Holdings, upon
exercise, an amount in cash determined by reference to decreases ("Index Put
Warrants") or increases ("Index Call Warrants") in the level of a specified
index (an "Index") which may be based on one or more U.S. or foreign stocks,
bonds or other securities, one or more U.S. or foreign interest rates, one or
more currencies or currency units, or any combination of the foregoing, or
determined by reference to the differential between any two Indices ("Index
Spread Warrants" and, together with the Index Put Warrants and the Index Call
Warrants, the "Index Warrants") and (v) warrants entitling the holders thereof
to receive from Holdings, upon exercise, an amount in cash determined by
reference to decreases ("Interest Rate Put Warrants") or increases ("Interest
Rate Call Warrants" and, together with the Interest Rate Put Warrants, the
"Interest Rate Warrants") in the yield or closing price of one or more specified
debt instruments issued either by the United States government or by a foreign
government (the "Debt Instrument"), in the interest rate or interest rate swap
rate established from time to time by one or more specified financial
institutions (the "Rate") or in any specified combination of Debt Instruments
and/or Rates, for aggregate proceeds of up to U.S.$497,131,485, or the
equivalent thereof in one or more foreign currencies or foreign currency units
(such amount being the aggregate proceeds to Holdings from all Debt Securities,
Debt Warrants, Currency Warrants, Index Warrants and Interest Rate Warrants
(collectively, the "Securities") issued and the exercise price of any Debt
Securities issuable upon the exercise of any Debt Warrants). The Securities may
be offered either together or separately and in one or more series in amounts,
at prices and on terms to be determined at the time of the offering. Unless
otherwise specified in an applicable Prospectus Supplement, the Securities will
be sold for, and the Debt Warrants, Currency Warrants, Index Warrants or
Interest Rate Warrants (collectively, the "Warrants") will be exercisable in,
United States dollars, and the principal of and interest, if any, on the Debt
Securities and the cash payments, if any, in respect of the Currency Warrants,
the Index Warrants and the Interest Rate Warrants will be payable in United
States dollars. If this Prospectus is being delivered in connection with the
offering and sale of Debt Securities, the specific designation, priority,
aggregate principal amount, the currency or currency unit for which the Debt
Securities may be purchased, the currency or currency unit in which the
principal and interest, if any, is payable, the rate (or method of calculation)
and time of payment of interest, if any, authorized denominations, maturity, any
redemption terms, any listing on a securities exchange and the initial public
offering price, a discussion of certain United States federal income tax,
accounting or other special considerations applicable thereto and any other
terms in connection with such offering and sale are set forth in an applicable
Prospectus Supplement. If this Prospectus is being delivered in connection with
the offering and sale of Warrants, the specific designation, aggregate number of
warrants, the currency or currency unit for which the warrants may be purchased,
the currency or currency unit in which the cash settlement value or the exercise
price, if applicable, is payable, the method of calculation of the cash
settlement value, if applicable, the date on which such warrants become
exercisable and the expiration date, provisions, if any, for the automatic
exercise and/or cancellation prior to the expiration date, the initial public
offering price, a discussion of certain United States federal income tax,
accounting or other special considerations applicable thereto and any other
terms in connection with such offering and sale will be set forth in an
applicable Prospectus Supplement.
The Debt Securities and the Debt Warrants may be issued in registered form
or bearer form with, in the case of Debt Securities, coupons attached. The
Currency Warrants, Index Warrants and Interest Rate Warrants will be issued in
registered form only. In addition, all or a portion of the Securities of a
series may be issued in global form. Debt Securities in bearer form will be
offered only outside the United States to non-United States persons and to
offices located outside the United States of certain United States financial
institutions. See "Description of Debt Securities--Limitations on Issuance of
Bearer Securities."
Discussions of certain United States federal income taxation consequences to
holders of Securities and certain of the risks associated with an investment in
Securities will be set forth in the applicable Prospectus Supplement.
--------------------------
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS
THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE
SECURITIES COMMISSION PASSED UPON THE ACCURACY OR
ADEQUACY OF THIS PROSPECTUS. ANY
REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
--------------------------
The Securities will be sold either through underwriters, dealers or agents,
or directly by Holdings. The applicable Prospectus Supplement sets forth the
names of any underwriters or agents (which may include Lehman Brothers Inc., a
subsidiary of Holdings ("Lehman Brothers")) involved in the sale of the
Securities in respect of which this Prospectus is being delivered, the proposed
amounts, if any, to be purchased by underwriters and the compensation, if any,
of such underwriters or agents.
--------------------------
This Prospectus together with the applicable Prospectus Supplement may also
be used by Lehman Brothers, in connection with offers and sales of Securities
related to market making transactions, by and through Lehman Brothers, at
negotiated prices related to prevailing market prices at the time of sale or
otherwise. Lehman Brothers may act as principal or agent in such transactions.
--------------------------
February 17, 1998
<PAGE>
AVAILABLE INFORMATION
Holdings is subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") and in accordance
therewith files reports and other information with the Securities and Exchange
Commission (the "SEC"). Such reports and information may be inspected and copied
at the public reference facilities maintained by the SEC at 450 Fifth Street,
N.W., Washington, D.C. 20549, and at the following Regional Offices of the SEC:
New York Regional Office, 7 World Trade Center, New York, New York 10048; and
Chicago Regional Office, Suite 1400, Northwestern Atrium Center, 500 W. Madison
Street, Chicago, Illinois 60661-2511; and copies of such material can be
obtained from the Public Reference Section of the SEC, Washington, D.C. 20549,
at prescribed rates. The SEC also maintains a Web site at http://www.sec.gov
that contains reports, proxy and information statements and other information
regarding registrants that file electronically with the SEC. Holdings' Common
Stock is listed on the New York Stock Exchange, Inc. (the "Exchange") and the
Pacific Stock Exchange. Holdings' 8 3/4% Notes Due 2002 and 8.30% Quarterly
Income Capital Securities Due 2035 are listed on the Exchange and Holdings' $55
Million Serial Zero Coupon Senior Notes Due May 16, 1998, Global
Telecommunications Stock Upside Note Securities-SM- Due 2000 and the AMEX Hong
Kong 30 Index Call Warrants Expiring 1998 and Select Technology Index Call
Warrants Expiring 1998 are listed on the American Stock Exchange, Inc. and
reports and other information concerning Holdings may also be inspected at the
offices of the Exchange at 20 Broad Street, New York, New York 10005 and at the
offices of the American Stock Exchange, Inc., 86 Trinity Place, New York, New
York 10006.
Holdings has filed with the SEC a registration statement on Form S-3
(herein, together with all amendments and exhibits, referred to as the
"Registration Statement") under the Securities Act of 1933, as amended (the
"Securities Act"). This Prospectus does not contain all of the information set
forth in the Registration Statement, certain parts of which are omitted in
accordance with the rules and regulations of the SEC. For further information,
reference is hereby made to the Registration Statement.
------------------------
DOCUMENTS INCORPORATED BY REFERENCE
The following documents previously filed by Holdings with the SEC pursuant
to the Exchange Act are hereby incorporated by reference in this Prospectus:
(1) Holdings' Annual Report on Form 10-K for the year ended November 30,
1996.
(2) Holdings' Quarterly Report on Form 10-Q for the fiscal quarters
ended February 28, 1997, May 31, 1997, and August 31, 1997.
(3) Holdings' Current Reports on Form 8-K dated January 8, 1997, March
26, 1997, June 26, 1997, September 4, 1997, September 30, 1997, and January
7, 1998.
Each document filed by Holdings pursuant to Section 13(a), 13(c), 14 or
15(d) of the Exchange Act after the date of this Prospectus and prior to the
termination of the offering of the Securities offered by an applicable
Prospectus Supplement shall be deemed to be incorporated by reference into this
Prospectus from the date of filing of such document. Any statement contained in
a document incorporated or deemed to be incorporated by reference herein shall
be deemed to be modified or superseded for purposes of the Registration
Statement and this Prospectus to the extent that a statement contained herein,
in an applicable Prospectus Supplement or in any subsequently filed document
which also is or is deemed to be incorporated by reference herein modifies or
supersedes such statement. Any such statement so modified or superseded shall
not be deemed, except as so modified or superseded, to constitute a part of the
Registration Statement or this Prospectus.
Holdings will provide without charge to each person, including any
beneficial owner of any Security, to whom a copy of this Prospectus is
delivered, upon the written or oral request of any such person, a copy of any or
all of the documents which are incorporated herein by reference, other than
exhibits to such documents (unless such exhibits are specifically incorporated
by reference into such documents). Requests should be directed to Mary J. Capko,
the Controller's Office, Lehman Brothers Holdings Inc., 3 World Financial
Center, 8th Floor, New York, New York 10285 (telephone (212) 526-0660).
2
<PAGE>
THE COMPANY
Lehman Brothers Holdings Inc. (together with its consolidated subsidiaries
hereinafter referred to as the "Company" unless the context otherwise requires)
is one of the leading global investment banks serving institutional, corporate,
government and high net worth individual clients and customers. The Company's
worldwide headquarters in New York and regional headquarters in London and Tokyo
are complemented by offices in additional locations in the United States,
Europe, the Middle East, Latin and South America and the Asia Pacific region.
The Company's business includes capital raising for clients through
securities underwriting and direct placements; corporate finance and strategic
advisory services; merchant banking; securities sales and trading; institutional
asset management; research; and the trading of foreign exchange, derivative
products and certain commodities. The Company acts as a market maker in all
major equity and fixed income products in both the domestic and international
markets. Lehman Brothers is a member of all principal securities and commodities
exchanges in the United States, as well as the National Association of
Securities Dealers, Inc. ("NASD"), and holds memberships or associate
memberships on several principal international securities and commodities
exchanges, including the London, Paris, Tokyo, Hong Kong, Frankfurt and Milan
stock exchanges.
Holdings was incorporated in Delaware on December 29, 1983. Holdings'
principal executive offices are located at 3 World Financial Center, New York,
New York 10285 (telephone (212) 526-7000).
USE OF PROCEEDS
Except as otherwise may be set forth in an applicable Prospectus Supplement
accompanying this Prospectus, Holdings intends to apply the net proceeds from
the sale of the Securities for general corporate purposes.
RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth the ratio of earnings to fixed charges of the
Company for each of the two years in the period ended December 31, 1993, the
eleven months ended November 30, 1994, the two years ended November 30, 1996 and
for the nine months ended August 31, 1997:
<TABLE>
<CAPTION>
ELEVEN MONTHS
YEAR ENDED ENDED YEAR ENDED NINE MONTHS ENDED
DECEMBER 31, NOVEMBER 30, NOVEMBER 30, AUGUST 31,
---------------------- ----------------- -------------------- ---------------------
1992 1993 1994 1995 1996 1997
----- --------- ----------------- --------- --------- ---------------------
<S> <C> <C> <C> <C> <C>
* 1.00 1.03 1.03 1.06 1.07
</TABLE>
------------------------
* Earnings were inadequate to cover fixed charges and would have had to
increase approximately $247 million in 1992 in order to cover the
deficiency.
In computing the ratio of earnings to fixed charges, "earnings" consist of
earnings from continuing operations before income taxes and fixed charges.
"Fixed charges" consist principally of interest expense and one-third of office
rentals and one-fifth of equipment rentals, which are deemed to be
representative of the interest factor.
3
<PAGE>
DESCRIPTION OF DEBT SECURITIES
The Debt Securities will constitute either Senior Debt (as defined below) or
Subordinated Debt (as defined below) of Holdings. The Debt Securities
constituting Senior Debt will be issued under an indenture, dated as of
September 1, 1987, between Holdings and Citibank, N.A., Trustee, as supplemented
and amended by Supplemental Indentures dated as of November 25, 1987, as of
November 27, 1990, as of September 13, 1991, as of October 4, 1993 and as of
October 1, 1995 (the "Senior Indenture"), and the Debt Securities constituting
Subordinated Debt will be issued under an indenture between Holdings and The
Chase Manhattan Bank, as successor to Chemical Bank, Trustee, as amended and
supplemented by the Supplemental Indenture dated as of February 1, 1996 (the
"Subordinated Indenture"). The Senior Indenture and the Subordinated Indenture
are hereinafter collectively referred to as the "Indentures" and, individually,
as an "Indenture". Each Indenture will incorporate by reference certain Standard
Multiple-Series Indenture Provisions, filed with the SEC on July 30, 1987 and as
amended and refiled with the SEC on November 16, 1987. This Prospectus contains
descriptions of all material provisions of the Indentures. The summary of such
provisions of the Indentures does not purport to be complete; copies of such
Indentures are filed as exhibits to the Registration Statement of which this
Prospectus is a part. All articles and sections of the applicable Indenture, and
all capitalized terms set forth below, have the meanings specified in the
applicable Indenture.
GENERAL
Neither Indenture limits the amount of debentures, notes or other evidences
of indebtedness which may be issued thereunder. Each Indenture provides that
Debt Securities may be issued from time to time in one or more series. Since
Holdings, as a holding company, does not have any significant assets other than
the equity securities of its subsidiaries, its cash flow and consequent ability
to service its debt, including the Debt Securities, are dependent upon the
earnings of its subsidiaries and the distribution of those earnings to Holdings,
or upon loans or other payments of funds by those subsidiaries to Holdings.
Holdings' subsidiaries, including Lehman Brothers, are separate and distinct
legal entities and will have no obligation, contingent or otherwise, to pay any
interest or principal on the Debt Securities or to make any funds available
therefor, whether by dividends, loans or other payments. Dividends, loans and
other payments by Lehman Brothers are restricted by net capital and other rules
of various regulatory bodies. See "Capital Requirements." The payment of
dividends by Holdings' subsidiaries is contingent upon the earnings of those
subsidiaries and is subject to various business considerations in addition to
net capital requirements and contractual restrictions.
Since the Debt Securities will be obligations of a holding company, the
ability of holders of the Debt Securities to benefit from any distribution of
assets of any subsidiary upon the liquidation or reorganization of such
subsidiary is subordinate to the prior claims of present and future creditors of
such subsidiary.
Reference is made to the applicable Prospectus Supplement for the following
terms and other information with respect to the Debt Securities being offered
thereby: (1) the title of such Debt Securities and whether such Debt Securities
will be Senior Debt or Subordinated Debt; (2) any limit on the aggregate
principal amount of such Debt Securities; (3) whether the Debt Securities are to
be issuable as Registered Securities or Bearer Securities or both, and if Bearer
Securities are issued, whether Bearer Securities may be exchanged for Registered
Securities and the circumstances and places for such exchange, if permitted; (4)
whether the Debt Securities are to be issued in whole or in part in the form of
one or more temporary or permanent global Debt Securities ("Global Securities")
in registered or bearer form and, if so, the identity of the depositary, if any,
for such Global Security or Securities; (5) the date or dates (or manner of
determining the same) on which such Debt Securities will mature; (6) the rate or
rates (or manner of determining the same) at which such Debt Securities will
bear interest, if any, and the date or dates from which such interest will
accrue; (7) the dates (or manner of determining the same) on which such interest
will be payable and the Regular Record Dates for such Interest Payment Dates for
Debt Securities which are Registered Securities, and the extent to which, or the
manner in which, any interest payable on a
4
<PAGE>
temporary or permanent global Debt Security on an Interest Payment Date will be
paid if other than in the manner described under "Global Securities" below; (8)
any mandatory or optional sinking fund or analogous provisions; (9) each office
or agency where, subject to the terms of the applicable Indenture as described
below under "Payment and Paying Agents", the principal of and premium, if any,
and interest, if any, on the Debt Securities will be payable and each office or
agency where, subject to the terms of the applicable Indenture as described
below under "Denominations, Registration and Transfer," the Debt Securities may
be presented for registration of transfer or exchange; (10) the date, if any,
after which, and the price or prices in the currency or currency unit in which,
such Debt Securities are payable pursuant to any optional or mandatory
redemption provision; (11) any provisions for payment of additional amounts for
taxes and any provision for redemption, in the event the Company must comply
with reporting requirements in respect of a Debt Security or must pay such
additional amounts in respect of any Debt Security; (12) the terms and
conditions, if any, upon which the Debt Securities of such series may be
repayable prior to maturity at the option of the holder thereof (which option
may be conditional) and the price or prices in the currency or currency unit in
which such Debt Securities are payable; (13) the denominations in which any Debt
Securities which are Registered Securities will be issuable if other than
denominations of $1,000 and any integral multiple thereof, and the denomination
or denominations in which any Debt Securities which are Bearer Securities will
be issuable if other than the denomination of $5,000; (14) the currency,
currencies or currency units for which such Debt Securities may be purchased and
the currency, currencies or currency units in which the principal of and
interest, if any, on such Debt Securities may be payable; (15) any index used to
determine the amount of payments of principal of and premium, if any, and
interest, if any, on such Debt Securities; (16) the terms and conditions, if
any, pursuant to which such Debt Securities may be converted or exchanged for
other securities of Holdings or any other person; (17) the terms and conditions,
if any, pursuant to which the principal of and premium if any, and interest, if
any, on such Debt Securities are payable at the election of Holdings or the
holder thereof, in securities or other property; and (18) other terms of the
Debt Securities. (Section 301).
If any of the Debt Securities are sold for foreign currencies or foreign
currency units or if the principal of or interest, if any, on any series of Debt
Securities is payable in foreign currencies or foreign currency units, the
restrictions, elections, tax consequences, specific terms and other information
with respect to such issue of Debt Securities and such currencies or currency
units will be set forth in an applicable Prospectus Supplement relating thereto.
One or more series of Debt Securities may be sold at a substantial discount
below their stated principal amount, bearing no interest or interest at a rate
which at the time of issuance is below market rates. Federal income tax
consequences and special considerations applicable to any such series will be in
an applicable Prospectus Supplement.
SENIOR DEBT
The Debt Securities constituting part of the senior debt of Holdings (the
"Senior Debt") will rank equally with all other unsecured debt of Holdings
except Subordinated Debt.
SUBORDINATED DEBT
The Debt Securities constituting part of the subordinated debt of Holdings
(the "Subordinated Debt") will be subordinate and junior in the right of
payment, to the extent and in the manner set forth in the Subordinated
Indenture, to all present or future Senior Debt. "Senior Debt" is defined to
mean (a) any indebtedness for money borrowed or evidenced by bonds, notes,
debentures or similar instruments, (b) indebtedness under capitalized leases,
(c) any indebtedness representing the deferred and unpaid purchase price of any
property or business, and (d) all deferrals, renewals, extensions and refundings
of any such indebtedness or obligation; except that the following does not
constitute Senior Debt: (i) indebtedness evidenced by the Subordinated Debt,
(ii) indebtedness which is expressly made equal in right of payment with the
Subordinated Debt or subordinate and subject in right of payment to the
Subordinated Debt, (iii)
5
<PAGE>
indebtedness for goods or materials purchased in the ordinary course of business
or for services obtained in the ordinary course of business or indebtedness
consisting of trade payables or (iv) indebtedness which is subordinated to any
obligation of Holdings of the type specified in clauses (a) through (d) above.
The effect of clause (iv) is that Holdings may not issue, assume or guaranty any
indebtedness for money borrowed which is junior to the Senior Debt and senior to
the Subordinated Debt. (Subordinated Indenture Section 1401).
Upon the failure to pay the principal or premium, if any, on Senior Debt
when due or upon the maturity of any Senior Debt by lapse of time, acceleration
or otherwise, all principal thereof, interest thereon, if any, and other amounts
due in connection therewith shall first be paid in full, before any payment is
made on account of the principal, premium, if any, or interest, if any, on the
Subordinated Debt or to acquire any of the Subordinated Debt or on account of
the redemption, sinking fund or analogous provisions in the Subordinated
Indenture. (Subordinated Indenture Section 1402). Upon any distribution of
assets of Holdings pursuant to any dissolution, winding up, liquidation or
reorganization of Holdings, payment of the principal, premium, if any, and
interest, if any, on the Subordinated Debt will be subordinated, to the extent
and in the manner set forth in the Subordinated Indenture, to the prior payment
in full of all Senior Debt. (Subordinated Indenture Section 1403). By reason of
such subordination, in the event of insolvency, creditors of Holdings who are
holders of Senior Debt may recover more ratably than the holders of Subordinated
Debt.
DENOMINATIONS, REGISTRATION AND TRANSFER
Unless otherwise provided with respect to a series of Debt Securities, the
Debt Securities will be issuable as Registered Securities without coupons and in
denominations of $1,000 or any integral multiple thereof. Debt Securities of a
series may be issuable in whole or in part in the form of one or more Global
Securities, as described below under "Global Securities." One or more Global
Securities will be issued in a denomination or aggregate denominations equal to
the aggregate principal amount of Debt Securities of the series to be
represented by such Global Security or Securities. If so provided with respect
to a series of Debt Securities, Debt Securities of such series will be issuable
solely as Bearer Securities with coupons attached or as both Registered
Securities and Bearer Securities. (Section 201).
In connection with the sale during the "restricted period" as defined in
Section 1.163-5(c)(2)(i)(D)(7) of the United States Treasury Regulations
(generally, the first 40 days after the closing date and, with respect to unsold
allotments, until sold) no Bearer Security shall be mailed or otherwise
delivered to any location in the United States (as defined under "Limitations on
Issuance of Bearer Securities"). A Bearer Security in definitive form (including
interests in a permanent Global Security) may be delivered only if the Person
entitled to receive such Bearer Security furnishes written certification, in the
form required by the applicable Indenture, to the effect that such Bearer
Security is not owned by or on behalf of a United States person (as defined
under "Limitations on Issuance of Bearer Securities"), or, if a beneficial
interest in such Bearer Security is owned by or on behalf of a United States
person, that such United States person (i) acquired and holds the Bearer
Security through a foreign branch of a United States financial institution, (ii)
is a foreign branch of a United States financial institution purchasing for its
own account or resale (and in either case, (i) or (ii), such financial
institution agrees to comply with the requirements of Section 165(j)(3)(A), (B)
or (C) of the Internal Revenue Code of 1986, as amended (the "Code"), and the
regulations thereunder) or (iii) is a financial institution purchasing for
resale during the restricted period only to non-United States persons outside
the United States (Sections 303, 304). See "Global Securities-- Bearer Debt
Securities" and "Limitations on Issuance of Bearer Securities."
Registered Securities of any series (other than a Global Security) will be
exchangeable for other Registered Securities of the same series and of a like
aggregate principal amount and tenor of different authorized denominations. In
addition, if Debt Securities of any series are issuable as both Registered
Securities and as Bearer Securities, at the option of the Holder upon request
confirmed in writing, and subject to the terms of the applicable Indenture,
Bearer Securities (with all unmatured coupons, except as
6
<PAGE>
provided below, and all matured coupons in default) of such series will be
exchangeable into Registered Securities of the same series of any authorized
denominations and of a like aggregate principal amount and tenor. Unless
otherwise indicated in an applicable Prospectus Supplement, any Bearer Security
surrendered in exchange for a Registered Security between a Regular Record Date
or a Special Record Date and the relevant date for payment of interest shall be
surrendered without the coupon relating to such date for payment of interest and
interest will not be payable in respect of the Registered Security issued in
exchange for such Bearer Security, but will be payable only to the Holder of
such coupon when due in accordance with the terms of the applicable Indenture.
(Section 305). Except as provided in an applicable Prospectus Supplement, Bearer
Securities will not be issued in exchange for Registered Securities.
Debt Securities may be presented for exchange as provided above, and
Registered Securities (other than a Global Security) may be presented for
registration of transfer (with the form of transfer endorsed thereon duly
executed), at the office of the Security Registrar or at the office of any
transfer agent designated by Holdings for such purpose with respect to any
series of Debt Securities and referred to in an applicable Prospectus
Supplement, without service charge and upon payment of any taxes and other
governmental charges as described in each Indenture. Such transfer or exchange
will be effected upon the Security Registrar or such transfer agent, as the case
may be, being satisfied with the documents of title and identity of the person
making the request. Holdings has appointed each Trustee as Security Registrar
under the applicable Indenture. (Section 305). If a Prospectus Supplement refers
to any transfer agents (in addition to the Security Registrar) initially
designated by Holdings with respect to any series of Debt Securities, Holdings
may at any time rescind the designation of any such transfer agent or approve a
change in the location through which any such transfer agent acts, except that,
if Debt Securities of a series are issuable only as Registered Securities,
Holdings will be required to maintain a transfer agent in each Place of Payment
for such series and, if Debt Securities of a series are issuable as Bearer
Securities, Holdings will be required to maintain (in addition to the Security
Registrar) a transfer agent in a Place of Payment for such series located
outside the United States. Holdings may at any time designate additional
transfer agents with respect to any series of Debt Securities. (Section 1002).
In the event of any redemption in part, Holdings shall not be required to
(i) issue, register the transfer of or exchange Debt Securities of any series
during a period beginning at the opening of business 15 days before any
selection of Debt Securities of that series to be redeemed and ending at the
close of business on (A) if Debt Securities of the series are issuable only as
Registered Securities, the day of mailing of the relevant notice of redemption
and (B) if Debt Securities of the series are issuable as Bearer Securities, the
day of the first publication of the relevant notice of redemption or, if Debt
Securities of the series are also issuable as Registered Securities and there is
no publication, the mailing of the relevant notice of redemption; (ii) register
the transfer of or exchange any Registered Security, or portion thereof, called
for redemption, except the unredeemed portion of any Registered Security being
redeemed in part; or (iii) exchange any Bearer Security called for redemption,
except to exchange such Bearer Security for a Registered Security of that series
and like tenor which is immediately surrendered for redemption. (Section 305).
PAYMENT AND PAYING AGENTS
Unless otherwise indicated in an applicable Prospectus Supplement, payment
of principal of (and premium, if any) and any interest on Bearer Securities will
be payable, subject to any applicable laws and regulations, at the offices of
such Paying Agents outside the United States as Holdings may designate from time
to time, at the option of the Holder, by check or by transfer to an account
maintained by the payee with a bank located outside the United States. (Sections
307 and 1002). Unless otherwise indicated in an applicable Prospectus
Supplement, payment of interest on Bearer Securities on any Interest Payment
Date will be made only against surrender of the coupon relating to such Interest
Payment Date. (Section 1001). No payment of interest on a Bearer Security will
be made unless on the earlier of the date of the first such
7
<PAGE>
payment by Holdings or the delivery by Holdings of the Bearer Security in
definitive form (including interests in a permanent Global Security) (the
"Certification Date"), a written certificate in the form and to the effect
described under "Denominations, Registration and Transfer" is provided to
Holdings. No payment with respect to any Bearer Security will be made at any
office or agency of Holdings in the United States or by check mailed to any
address in the United States or by transfer to an account maintained with a bank
located in the United States. Notwithstanding the foregoing, payment of
principal of (and premium, if any) and interest on Bearer Securities denominated
and payable in U.S. dollars will be made at the office of Holdings' Paying Agent
in the Borough of Manhattan, The City of New York if, and only if, payment of
the full amount thereof in U.S. dollars at all offices or agencies outside the
United States is illegal or effectively precluded by exchange controls or other
similar restrictions. (Section 1002).
Unless otherwise indicated in an applicable Prospectus Supplement, payment
of principal of (and premium, if any) and any interest on Registered Securities
(other than a Global Security) will be made at the office of such Paying Agent
or Paying Agents as Holdings may designate from time to time, except that at the
option of Holdings payment of any interest may be made (i) by check mailed to
the address of the Person entitled thereto as such address shall appear in the
Security Register or (ii) by wire transfer to an account maintained by the
Person entitled thereto as specified in the Security Register. (Sections 305,
307, 1002). Unless otherwise indicated in an applicable Prospectus Supplement,
payment of any instalment of interest on Registered Securities will be made to
the Person in whose name such Registered Security is registered at the close of
business on the Regular Record Date for such interest payment. (Section 307).
Unless otherwise indicated in an applicable Prospectus Supplement, the
principal office of each Trustee under the applicable Indenture in The City of
New York will be designated as Holdings' sole Paying Agent for payments with
respect to Debt Securities which are issuable solely as Registered Securities
and as Holdings' Paying Agent in the Borough of Manhattan, The City of New York,
for payments with respect to Debt Securities (subject to the limitations
described above in the case of Bearer Securities) which may be issuable as
Bearer Securities. Any Paying Agents outside the United States and any other
Paying Agents in the United States initially designated by Holdings for the Debt
Securities will be named in an applicable Prospectus Supplement. Holdings may at
any time designate additional Paying Agents or rescind the designation of any
Paying Agents or approve a change in the office through which any Paying Agent
acts, except that, if Debt Securities of a series are issuable only as
Registered Securities, Holdings will be required to maintain a Paying Agent in
each Place of Payment for such series, and if Debt Securities of a series may be
issuable as Bearer Securities, Holdings will be required to maintain (i) a
Paying Agent in the Borough of Manhattan, The City of New York for payments with
respect to any Registered Securities of the series (and for payments with
respect to Bearer Securities of the series in the circumstances described above,
but not otherwise), and (ii) a Paying Agent in a Place of Payment located
outside the United States where Debt Securities of such series and any coupons
appertaining thereto may be presented and surrendered for payment; provided that
if the Debt Securities of such series are listed on The Luxembourg Stock
Exchange (the "Stock Exchange") or any other stock exchange located outside the
United States and such stock exchange shall so require, Holdings will maintain a
Paying Agent in Luxembourg or any other required city located outside the United
States, as the case may be, for the Debt Securities of such series. (Section
1002).
All moneys paid by Holdings to a Paying Agent for the payment of principal
of (and premium, if any) or interest on any Debt Security which remain unclaimed
at the end of two years after such principal, premium or interest shall have
become due and payable will be repaid to Holdings and the Holder of such Debt
Security or any coupon will thereafter look only to Holdings for payment
thereof. (Section 1003).
LIMITATION ON LIENS
So long as any Debt Securities remain outstanding, unless an applicable
Prospectus Supplement relating thereto provides otherwise, Holdings will not,
and will not permit any Designated Subsidiary (as defined below), directly or
indirectly, to create, issue, assume, incur or guarantee any indebtedness for
8
<PAGE>
money borrowed which is secured by a mortgage, pledge, lien, security interest
or other encumbrance of any nature on any of the present or future common stock
of a Designated Subsidiary unless the Debt Securities and, if Holdings so
elects, any other indebtedness of Holdings ranking at least PARI PASSU with the
Debt Securities, shall be secured equally and ratably with (or prior to) such
other secured indebtedness for money borrowed so long as it is outstanding.
(Section 1005).
The term "Designated Subsidiary" means any present or future consolidated
subsidiary of Holdings, the consolidated net worth of which constitutes at least
5% of the consolidated net worth of Holdings. As of August 31, 1997, Holdings'
Designated Subsidiaries were Lehman Brothers, Lehman Brothers Holdings PLC,
Lehman Brothers UK Holdings Limited, Lehman Brothers U.K. Holdings (Delaware)
Inc., Lehman Brothers International (Europe), Lehman Brothers Financial Products
Inc., Lehman Brothers Special Financing Inc., Lehman Brothers Commercial Paper
Inc. and Lehman Brothers Finance S.A. (Geneva).
EVENTS OF DEFAULT
Except as may otherwise be set forth in an applicable Prospectus Supplement
relating to a series of Debt Securities, the following are Events of Default
under the Indenture with respect to Debt Securities of such series: (a) failure
to pay principal of or premium, if any, on any Debt Security of that series when
due; (b) failure to pay interest, if any, on any Debt Security of that series
and any related coupons when due, continued for 30 days; (c) failure to deposit
any sinking fund payment or analogous obligation, when due, continued for 30
days, in respect of any Debt Security of that series; (d) failure to perform any
other covenant of Holdings in the Indenture (other than a covenant included in
the applicable Indenture solely for the benefit of a series of Debt Securities
other than that series), continued for 90 days after written notice as provided
in the Indenture; (e) certain events in bankruptcy, insolvency or reorganization
in respect of Holdings; and (f) any other Event of Default provided with respect
to Debt Securities of that series. (Section 501). An Event of Default with
respect to a particular series of Debt Securities does not necessarily
constitute an Event of Default with respect to any other series of Debt
Securities issued under the same or another Indenture. The Trustee may withhold
notice to the Holders of any series of Debt Securities of any default with
respect to such series (except in the payment of principal, premium or interest,
if any) if it considers such withholding to be in the interests of such Holders.
(Section 602).
If an Event of Default with respect to Debt Securities of any series at the
time outstanding occurs and is continuing, unless the principal of all of the
Debt Securities of such series shall have already become due and payable, either
the Trustee or the Holders of at least 25% in principal amount of the
outstanding Debt Securities of that series may declare the principal amount (or,
if the Debt Securities of that series are Original Issue Discount Securities,
such portion of the principal amount as may be specified in the terms of the
series) of all the Debt Securities of that series to be due and payable
immediately. At any time after a declaration of acceleration with respect to
Debt Securities of any series has been made, but before a judgment or decree
based on acceleration has been obtained and entered, the Holders of a majority
in principal amount of the outstanding Debt Securities of that series may, under
certain circumstances, rescind and annul such acceleration. (Section 502). For
information as to waiver of defaults, see "Meetings, Modification and Waiver."
Each Indenture provides that the Trustee will be under no obligation,
subject to the duty of the Trustee during default to act with the required
standard of care, to exercise any of its rights or powers under such Indenture
at the request or direction of any of the Holders, unless such Holders shall
have offered to the Trustee reasonable indemnity. (Section 603). Subject to such
provisions for indemnification of the Trustee, the Holders of a majority in
principal amount of the outstanding Debt Securities of any series will have the
right to direct the time, method and place of conducting any proceeding for any
remedy available to the Trustee, or exercising any trust or power conferred on
the Trustee, with respect to the Debt Securities of that series. (Section 512).
9
<PAGE>
Holdings will be required to furnish to each Trustee annually a statement as
to the performance by Holdings of certain of its obligations under the
applicable Indenture and as to any default in such performance. (Section 1006).
SATISFACTION AND DISCHARGE
Except as may otherwise be set forth in an applicable Prospectus Supplement
relating to a series of Debt Securities, each Indenture provides that Holdings
shall be discharged from its obligations under the Debt Securities of such
series (with certain exceptions) at any time prior to the Stated Maturity or
redemption thereof when (a) Holdings has irrevocably deposited with the
applicable Trustee, in trust, (i) sufficient funds in the currency or currency
unit in which the Debt Securities of such series are payable to pay the
principal of (and premium, if any), and interest, if any, to Stated Maturity (or
redemption) on, the Debt Securities of such series, or (ii) such amount of
direct obligations of, or obligations the principal of and interest, if any, on
which are fully guaranteed by, the government which issued the currency in which
the Debt Securities of such series are payable, and which are not subject to
prepayment, redemption or call, as will, together with the predetermined and
certain income to accrue thereon without consideration of any reinvestment
thereof, be sufficient to pay when due the principal of (and premium, if any),
and interest, if any, to Stated Maturity (or redemption) on, the Debt Securities
of such series, or (iii) such combination of such funds and securities as
described in (i) and (ii), respectively, as will, together with the
predetermined and certain income to accrue on any such securities as described
in (ii), be sufficient to pay when due the principal of (and premium, if any),
and interest, if any, to Stated Maturity (or redemption) on, the Debt Securities
of such series and (b) Holdings has paid all other sums payable with respect to
the Debt Securities of such series and (c) certain other conditions are met.
Upon such discharge, the Holders of the Debt Securities of such series shall no
longer be entitled to the benefits of the Indenture, except for certain rights,
including registration of transfer and exchange of the Debt Securities of such
series and replacement of lost, stolen or mutilated Debt Securities, and shall
look only to such deposited funds or obligations for payment. (Sections 401 and
403).
DEFEASANCE OF CERTAIN OBLIGATIONS
If the terms of the Debt Securities of any series so provide, Holdings may
omit to comply with the restrictive covenants in Section 801 ("Company May
Consolidate, Etc., Only on Certain Terms"), Section 1005 ("Limitations on Liens
on Common Stock of Designated Subsidiaries") and any other specified covenant
and any such omission with respect to such Sections shall not be an Event of
Default with respect to the Debt Securities of such series, if (a) Holdings has
irrevocably deposited with the applicable Trustee, in trust, (i) sufficient
funds in the currency or currency unit in which the Debt Securities of such
series are payable to pay the principal of (and premium, if any), and interest,
if any, to Stated Maturity (or redemption) on, the Debt Securities of such
series, or (ii) such amount of direct obligations of, or obligations the
principal of and interest, if any, on which are fully guaranteed by, the
government which issued the currency in which the Debt Securities of such series
are payable and which are not subject to prepayment, redemption or call, as
will, together with the predetermined and certain income to accrue thereon
without consideration of any reinvestment thereof, be sufficient to pay when due
the principal of (and premium, if any), and interest, if any, to Stated Maturity
(or redemption) on, the Debt Securities of such series or, (iii) such
combination of such funds and securities as described in (i) and (ii),
respectively, as will, together with the predetermined and certain income to
accrue on any such securities as described in (ii), be sufficient to pay when
due the principal of (and premium, if any), and interest, if any, to Stated
Maturity (or redemption) on, the Debt Securities of such series and (b) certain
other conditions are met. The obligations of Holdings under the Indenture with
respect to the Debt Securities of such series, other than with respect to the
covenants referred to above shall remain in full force and effect. (Section
1009).
10
<PAGE>
MEETINGS, MODIFICATION AND WAIVER
Modifications and amendments of either Indenture may be made by Holdings and
the applicable Trustee with the consent of the Holders of not less than 66 2/3%
in principal amount of the Outstanding Debt Securities of each series issued
under such Indenture affected by such modification or amendment; PROVIDED,
HOWEVER, that no such modification or amendment may, without the consent of the
Holder of each Outstanding Debt Security affected thereby, (a) change the Stated
Maturity of the principal of, or any instalment of principal of or interest, if
any, on, any Debt Security, (b) reduce the principal amount of, or the premium,
if any, or interest, if any, on, any Debt Security, (c) change any obligation of
Holdings to pay additional amounts, (d) reduce the amount of principal of an
Original Issue Discount Security payable upon acceleration of the Maturity
thereof, (e) adversely affect the right of repayment or repurchase, if any, at
the option of the Holder, (f) reduce the amount, or postpone the date fixed for,
any payment under any sinking fund or analogous provision, (g) change the
currency or currency unit of payment of principal of or premium, if any, or
interest, if any, on any Debt Security, (h) change or eliminate the right, if
any, to elect payment in a coin or currency or currency unit other than that in
which Debt Securities which are Registered Securities are denominated or stated
to be payable, (i) impair the right to institute suit for the enforcement of any
payment on or with respect to any Debt Security, (j) reduce the percentage in
principal amount of Outstanding Debt Securities of any series, the consent of
the Holders of which is required for modification or amendment of the applicable
Indenture or for waiver of compliance with certain provisions of the applicable
Indenture or for waiver of certain defaults, (k) reduce the requirements
contained in either Indenture for quorum or voting, or (l) change any obligation
of Holdings to maintain an office or agency in the places and for the purposes
required in the applicable Indenture. (Section 902).
The Holders of not less than a majority in principal amount of the
Outstanding Debt Securities of any series may on behalf of the Holders of all
Debt Securities of that series waive, insofar as that series is concerned,
compliance by Holdings with certain restrictive provisions of the applicable
Indenture. (Section 1007). The Holders of not less than a majority in principal
amount of the Outstanding Debt Securities of any series may on behalf of the
Holders of all Debt Securities of that series and any coupons appertaining
thereto waive any past default under the applicable Indenture with respect to
that series, except a default in the payment of the principal of or premium, if
any, or interest, if any, on any Debt Security of that series or in the payment
of any sinking fund instalment or analogous obligation or in respect of a
provision which under the applicable Indenture cannot be modified or amended
without the consent of the Holder of each Outstanding Debt Security of that
series affected. (Section 513).
Each Indenture contains provisions for convening meetings of the Holders of
Debt Securities of a series if Debt Securities of that series are issuable as
Bearer Securities. A meeting may be called at any time by the applicable
Trustee, and also, upon request, by Holdings or Holders of at least 10% in
principal amount of the Outstanding Debt Securities of such series, in any such
case upon notice given in accordance with "Notices" below. (Section 1302).
Except as limited by the proviso in the second preceding paragraph, any
resolution presented at a meeting or adjourned meeting at which a quorum is
present may be adopted by the affirmative vote of the Holders of a majority in
principal amount of the Outstanding Debt Securities of that series; PROVIDED,
HOWEVER, that, except as limited by the proviso in the second preceding
paragraph, any resolution with respect to any consent or waiver which may be
given by the Holders of not less than 66 2/3% in principal amount of the
Outstanding Debt Securities of a series may be adopted at a meeting or an
adjourned meeting at which a quorum is present only by the affirmative vote of
66 2/3% in principal amount of the Outstanding Debt Securities of that series;
and PROVIDED, FURTHER, that, except as limited by the proviso in the second
preceding paragraph, any resolution with respect to any request, demand,
authorization, direction, notice, consent, waiver or other action which may be
made, given or taken by the Holders of a specified percentage, which is less
than a majority, in principal amount of Outstanding Debt Securities of a series
may be adopted at a meeting or adjourned meeting duly reconvened at which a
quorum is present by the affirmative vote of the Holders of such specified
percentage in principal amount of the Outstanding Debt Securities of that
series. Any resolution passed or decision taken at any meeting
11
<PAGE>
of Holders of Debt Securities of any series duly held in accordance with the
applicable Indenture will be binding on all Holders of Debt Securities of that
series and the related coupons. The quorum at any meeting called to adopt a
resolution, and at any reconvened meeting, will be persons holding or
representing a majority in principal amount of the Outstanding Debt Securities
of a series; PROVIDED, HOWEVER, that if any action is to be taken at such
meeting with respect to a consent or waiver which may be given by the Holders of
not less than 66 2/3% in principal amount of the Outstanding Debt Securities of
a series, the persons holding or representing 66 2/3% in principal amount of the
Outstanding Debt Securities of such series will constitute a quorum (Section
1304).
CONSOLIDATION, MERGER AND SALE OF ASSETS
Holdings may, without the consent of any Holders of Outstanding Debt
Securities, consolidate or merge with or into, or transfer or lease its assets
substantially as an entirety to, any Person, and any other Person may
consolidate or merge with or into, or transfer or lease its assets substantially
as an entirety to, Holdings, PROVIDED that (i) the Person (if other than
Holdings) formed by such consolidation or into which Holdings is merged or which
acquires or leases the assets of Holdings substantially as an entirety is
organized under the laws of any United States jurisdiction and assumes Holdings'
obligations on the Debt Securities and under the Indenture, (ii) after giving
effect to the transaction, no Event of Default, and no event which, after notice
or lapse of time or both, would become an Event of Default, shall have happened
and be continuing, and (iii) certain other conditions are met. (Section 801).
NOTICES
Except as may otherwise be set forth in an applicable Prospectus Supplement
relating to a series of Debt Securities, notices to Holders of Bearer Securities
will be given by publication in a daily newspaper in the English language of
general circulation in The City of New York and in London, and so long as such
Bearer Securities are listed on the Stock Exchange and the Stock Exchange shall
so require, in a daily newspaper of general circulation in Luxembourg or, if not
practical, elsewhere in Western Europe. Such publication is expected to be made
in THE WALL STREET JOURNAL, the FINANCIAL TIMES and the LUXEMBURGER WORT.
Notices to Holders of Registered Securities will be given by mail to the
addresses of such Holders as they appear in the Security Register. (Sections 101
and 106).
TITLE
Title to any temporary global Debt Security or permanent global Debt
Security in bearer form or any Bearer Securities and any coupons appertaining
thereto will pass by delivery. Holdings, each Trustee and any agent of Holdings
or the applicable Trustee may treat the bearer of any Bearer Security and the
bearer of any coupon and the registered owner of any Registered Security as the
absolute owner thereof (whether or not such Debt Security or coupon shall be
overdue and notwithstanding any notice to the contrary) for the purpose of
making payment and for all other purposes. (Section 308).
REPLACEMENT OF DEBT SECURITIES AND COUPONS
Any mutilated Debt Security or a Debt Security with a mutilated coupon
appertaining thereto will be replaced by Holdings at the expense of the Holder
upon surrender of such Debt Security to the applicable Trustee. Debt Securities
or coupons that become destroyed, stolen or lost will be replaced by Holdings at
the expense of the Holder upon delivery to the applicable Trustee of the Debt
Security and coupons or evidence of the destruction, loss or theft thereof
satisfactory to Holdings and the applicable Trustee; in the case of any coupon
which becomes destroyed, stolen or lost, such coupon will be replaced by
issuance of a new Debt Security in exchange for the Debt Security to which such
coupon appertains. In the case of a destroyed, lost or stolen Debt Security or
coupon an indemnity satisfactory to the applicable Trustee and Holdings may be
required at the expense of the Holder of such Debt Security or coupon before a
replacement Debt Security will be issued. (Section 306).
12
<PAGE>
CONCERNING THE TRUSTEES
Business and other relationships (including other trusteeships) between, on
the one hand, Holdings and its affiliates and, on the other hand, the Trustee
under the Indenture pursuant to which any of the Debt Securities to which an
applicable Prospectus Supplement accompanying this Prospectus relates are
described in such Prospectus Supplement.
LIMITATIONS ON ISSUANCE OF BEARER SECURITIES
In compliance with United States federal tax laws and regulations, Bearer
Securities may not be offered or sold during the restricted period (as defined
under "Denominations, Registration and Transfer"), or delivered in definitive
form in connection with a sale during the restricted period, in the United
States or to United States persons other than to (a) the United States office of
(i) an international organization (as defined in Section 7701 (a)(18) of the
Code), (ii) a foreign central bank (as defined in Section 895 of the Code), or
(iii) any underwriter, agent, or dealer offering or selling Bearer Securities
during the restricted period (a "Distributor") pursuant to a written contract
with the issuer or with another Distributor, that purchases Bearer Securities
for resale or for its own account and agrees to comply with the requirements of
Section 165 (j)(3)(A), (B), or (C) of the Code, or (b) the foreign branch of a
United States financial institution purchasing for its own account or for
resale, which institution agrees to comply with the requirements of Section 165
(j)(3)(A), (B), or (C) of the Code. In addition, a sale of a Bearer Security may
be made during the restricted period to a United States person who acquired and
holds the Bearer Security on the Certification Date through a foreign branch of
a United States financial institution that agrees to comply with the
requirements of Section 165(j)(3)(A), (B) or (C) of the Code. Any Distributor
(including an affiliate of a Distributor) offering or selling Bearer Securities
during the restricted period must agree not to offer or sell Bearer Securities
in the United States or to United States persons (except as discussed above) and
must employ procedures reasonably designed to ensure that its employees or
agents directly engaged in selling Bearer Securities are aware of these
restrictions.
Bearer Securities and their interest coupons will bear a legend
substantially to the following effect: "Any United States person who holds this
obligation will be subject to limitations under the United States income tax
laws, including the limitations provided in Section 165(j) and 1287(a) of the
Internal Revenue Code."
Purchasers of Bearer Securities may be affected by certain limitations under
United States tax laws. See the applicable Prospectus Supplement for a summary
of material U.S. federal income tax consequences to United States persons
investing in Bearer Securities.
As used herein, "United States person" means a citizen or resident of the
United States, a corporation, partnership or other entity created or organized
in or under the laws of the United States and an estate or trust the income of
which is subject to United States federal income taxation regardless of its
source, and "United States" means the United States of America (including the
States and the District of Columbia) and its possessions including Puerto Rico,
the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern
Mariana Islands. The term "Non-United States Holder" means any Holder which is
not an United States person.
13
<PAGE>
DESCRIPTION OF WARRANTS
The Debt Warrants, Currency Warrants, Index Warrants and Interest Rate
Warrants are to be issued under separate warrant agreements (each a "Warrant
Agreement" and respectively a "Debt Warrant Agreement", a "Currency Warrant
Agreement", an "Index Warrant Agreement" and an "Interest Rate Warrant
Agreement") to be entered into between Holdings and one or more banks or trust
companies, as warrant agent (each a "Warrant Agent" and respectively a "Debt
Warrant Agent", a "Currency Warrant Agent", an "Index Warrant Agent" and an
"Interest Rate Warrant Agent"), all as shall be set forth in the Prospectus
Supplement relating to the Warrants being offered thereby. A form of each type
of Warrant Agreement, including a form of warrant certificate representing each
type of Warrant (each a "Warrant Certificate" and respectively a "Debt Warrant
Certificate", a "Currency Warrant Certificate", an "Index Warrant Certificate"
and an "Interest Rate Warrant Certificate"), reflecting the alternative
provisions that may be included in the Warrant Agreements to be entered into
with respect to particular offerings of Warrants, are incorporated by reference
as exhibits to the Registration Statement of which this Prospectus is a part.
The descriptions contained herein of the Warrant Agreements and the Warrant
Certificates and summaries of certain provisions of the Warrant Agreements and
the Warrant Certificates do not purport to be complete and are subject to, and
are qualified in their entirety by reference to, all the provisions of the
applicable Warrant Agreements and the Warrant Certificates, including the
definitions therein of certain terms not otherwise defined in this Prospectus.
Wherever particular sections of, or terms defined in, the Warrant Agreements are
referred to, such sections or defined terms are incorporated herein by
reference.
The particular terms of each issue of Warrants, as well as any modifications
or additions to the general terms of the applicable Warrant Agreement or Warrant
Certificate, will be described in the Prospectus Supplement relating to such
Warrants. Accordingly, for a description of the terms of a particular issue of
Warrants, reference must be made to the Prospectus Supplement relating thereto
and to the descriptions set forth below.
DEBT WARRANTS
Holdings may issue, together with Debt Securities, Currency Warrants, Index
Warrants or Interest Rate Warrants, or separately, Debt Warrants for the
purchase of Debt Securities. If any of the Debt Warrants are sold for foreign
currencies or foreign currency units or if any series of Debt Warrants is
exercisable in foreign currencies or foreign currency units, the restrictions,
elections, tax consequences, specific terms and other information with respect
to such issue of Debt Warrants and such currencies or currency units will be set
forth in an applicable Prospectus Supplement relating thereto.
If so specified in the applicable Prospectus Supplement, the Debt Warrants
may, in certain circumstances, be cancelled by Holdings prior to their
expiration date and the holders thereof will be entitled to receive only the
applicable Cancellation Amount. The Cancellation Amount may be either a fixed
amount or an amount that varies during the term of the Debt Warrants in
accordance with a schedule or formula.
GENERAL
The Prospectus Supplement will describe the terms of any Debt Warrants
offered thereby, the Debt Warrant Agreement relating to such Debt Warrants and
the Debt Warrant Certificates representing such Debt Warrants, including the
following: (1) the title of such Debt Warrants; (2) the aggregate amount of such
Debt Warrants; (3) the initial offering price of such Debt Warrants; (4) the
exercise price; (5) the currency or currency unit in which the initial offering
price and/or the exercise price of such Debt Warrants is payable; (6) whether
the Debt Warrants are to be issuable in registered or bearer form or both, and
if in bearer form, whether such Debt Warrants may be exchanged for Debt Warrants
in registered form and the circumstances and places for such exchange, if
permitted; (7) if applicable, the title and terms of related Debt Securities
with which such Debt Warrants are issued, the number of such Debt Warrants
issued with each such Debt Security and the date, if any, on and after which
such Debt Warrants and such Debt
14
<PAGE>
Securities will be separately transferable; (8) the title, aggregate principal
amount and terms of the Debt Securities purchasable upon exercise of all of such
Debt Warrants; (9) the principal amount of Debt Securities purchasable upon
exercise of each Debt Warrant and the price at which such principal amount of
Debt Securities may be purchased upon such exercise; (10) the date on which the
right to exercise such Debt Warrants shall commence and the date (the "Debt
Warrant Expiration Date") on which such right shall expire; (11) any minimum
number of Debt Warrants which must be exercised at any one time, other than upon
automatic exercise; (12) the maximum number, if any, of such Debt Warrants that
may, subject to election by Holdings, be exercised by all owners (or by any
person or entity) on any day; (13) any provisions for the automatic exercise of
such Debt Warrants; (14) whether and under what circumstances such Debt Warrants
may be cancelled by Holdings prior to expiration; (15) any other procedures and
conditions relating to the exercise of such Debt Warrants; (16) the identity of
the Debt Warrant Agent; (17) any national securities exchange on which such Debt
Warrants will be listed; (18) provisions, if any, for issuing such Debt Warrants
in certificated form; (19) if applicable, a discussion of certain United States
federal income tax, accounting or other special considerations applicable
thereto; and (20) any other terms of the Debt Warrants.
Debt Warrant Certificates will be exchangeable for new Debt Warrant
Certificates of different denominations and, if in registered form, may be
presented for registration of transfer and Debt Warrants may be exercised at the
corporate trust office of the Debt Warrant Agent or any other office indicated
in the Prospectus Supplement relating thereto (Section 3.1). Prior to the
exercise of Debt Warrants, holders of Debt Warrants will not be entitled to
payments of principal of (or premium, if any) or interest, if any, on the Debt
Securities purchasable upon such exercise, or to enforce any of the covenants in
the applicable Indenture (Section 4.1).
EXERCISE OF DEBT WARRANTS
Unless otherwise provided in the Prospectus Supplement, each Debt Warrant
will entitle the holder thereof to purchase for cash such principal amount of
Debt Securities at such exercise price as shall in each case be set forth in, or
be determinable as set forth in, the Prospectus Supplement relating to the Debt
Warrants offered thereby (Sections 2.1). Debt Warrants may be exercised at any
time up to the close of business on the Debt Warrant Expiration Date specified
in the Prospectus Supplement relating to the Debt Warrants offered thereby.
After the close of business on the Debt Warrant Expiration Date (or such later
date to which such Debt Warrant Expiration Date may be extended by Holdings),
unexercised Debt Warrants will become void (Section 2.2).
Debt Warrants may be exercised as set forth in the Prospectus Supplement
relating to the Debt Warrants offered thereby. Upon receipt of payment and the
Debt Warrant Certificate properly completed and duly executed at the corporate
trust office of the Debt Warrant Agent or any other office indicated in the
Prospectus Supplement, Holdings will, as soon as practicable, forward to the
person entitled thereto the Debt Securities purchasable upon such exercise. If
fewer than all of the Debt Warrants represented by such Debt Warrant Certificate
are exercised, a new Debt Warrant Certificate will be issued for the remaining
amount of Debt Warrants (Section 2.3).
OTHER INFORMATION
Other important information concerning Debt Warrants is set forth below
under "Certain Items Applicable to All Warrants--Modifications", "--Merger,
Consolidation, Sale or Other Dispositions",
"--Enforceability of Rights by Beneficial Owner; Governing Law" and "--Unsecured
Obligations of a Holding Company".
15
<PAGE>
CURRENCY WARRANTS
Holdings may issue, together with Debt Securities, Debt Warrants, Index
Warrants or Interest Rate Warrants, or separately, Currency Warrants (a) in the
form of Currency Put Warrants, entitling the owners thereof to receive from
Holdings the Currency Warrant Cash Settlement Value (as shall be defined in the
Prospectus Supplement) of the right to sell a specified amount of one currency
(whether U.S. dollars or a foreign currency or foreign currency unit) (a "Base
Currency") for a specified amount of a different currency (whether U.S. dollars
or a foreign currency or foreign currency unit) (a "Reference Currency"), (b) in
the form of Currency Call Warrants, entitling the owners thereof to receive from
Holdings the Currency Warrant Cash Settlement Value of the right to purchase a
specified amount of a Base Currency for a specified amount of a Reference
Currency, or (c) in such other form as shall be specified in the related
Prospectus Supplement. The Prospectus Supplement for an issue of Currency
Warrants will set forth the formula pursuant to which the Currency Warrant Cash
Settlement Value will be determined, including any multipliers, if applicable.
The Prospectus Supplement will describe the terms of any Currency Warrants
offered thereby, the Currency Warrant Agreement relating to such Currency
Warrants and the Currency Warrant Certificates representing such Currency
Warrants, including the following: (1) the title of such Currency Warrants;
(2) the aggregate amount of such Currency Warrants; (3) the initial offering
price of such Currency Warrants; (4) the exercise price, if any; (5) the
currency or currency unit in which the initial offering price, the exercise
price, if any, and the Currency Warrant Cash Settlement Value of such Currency
Warrants is payable; (6) the Base Currency and the Reference Currency for such
Currency Warrants; (7) whether such Currency Warrants shall be Currency Put
Warrants, Currency Call Warrants or otherwise; (8) the formula for determining
the Currency Warrant Cash Settlement Value, if applicable, of each Currency
Warrant;
(9) whether and under what circumstances a minimum and/or maximum expiration
value is applicable upon the expiration or exercise of such Currency Warrants;
(10) the effect or effects, if any, of the occurrence of a Market Disruption
Event or Force Majeure Event; (11) the date on which the right to exercise such
Currency Warrants shall commence and the date (the "Currency Warrant Expiration
Date") on which such right shall expire; (12) any minimum number of Currency
Warrants which must be exercised at any one time, other than upon automatic
exercise; (13) the maximum number, if any, of such Currency Warrants that may,
subject to election by Holdings, be exercised by all owners (or by any person or
entity) on any day; (14) any provisions for the automatic exercise of such
Currency Warrants other than at expiration; (15) whether and under what
circumstances such Currency Warrants may be cancelled by Holdings prior to their
expiration date; (16) any other procedures and conditions relating to the
exercise of such Currency Warrants; (17) the identity of the Currency Warrant
Agent; (18) any national securities exchange on which such Currency Warrants
will be listed; (19) provisions, if any, for issuing such Currency Warrants in
certificated form; (20) if such Currency Warrants are not issued in book-entry
form, the place or places at which payments in respect of such Currency Warrants
are to be made by Holdings; (21) if applicable, a discussion of certain United
States federal income tax, accounting or other special considerations applicable
thereto; and (22) any other terms of the Currency Warrants.
Other important information concerning Currency Warrants is set forth below
under "Certain Items Applicable to All Warrants--Modifications", "--Merger,
Consolidation, Sale or Other Dispositions",
"--Enforceability of Rights by Beneficial Owner; Governing Law" and "--Unsecured
Obligations of a Holding Company" and "Certain Items Applicable to Currency
Warrants, Index Warrants and Interest Rate Warrants--Exercise of Warrants",
"--Market Disruption and Force Majeure Events" and "--Settlement Currency" and
"--Listing".
INDEX WARRANTS
Holdings may issue, together with Debt Securities, Debt Warrants, Currency
Warrants or Interest Rate Warrants, or separately, Index Warrants (a) in the
form of Index Put Warrants, entitling the owners thereof to receive from
Holdings the Index Cash Settlement Value (as shall be defined in the Prospectus
16
<PAGE>
Supplement) in cash, which amount will be determined by reference to the amount,
if any, by which the Fixed Amount (as shall be defined in the Prospectus
Supplement) at the time of exercise exceeds the Index Value (as shall be defined
in the Prospectus Supplement), (b) in the form of Index Call Warrants, entitling
the owners thereof to receive from Holdings the Index Cash Settlement Value in
cash, which amount will be determined by reference to the amount, if any, by
which the Index Value at the time of exercise exceeds the Fixed Amount, (c) in
the form of Index Spread Warrants, entitling the owners thereof to receive from
Holdings the Index Cash Settlement Value in cash, which amount will be
determined by reference to the amount, if any, by which the Reference Index
Value (as shall be defined in the Prospectus Supplement) at the time of exercise
exceeds the Base Index Value (as shall be defined in the Prospectus Supplement)
or (d) in such other form as shall be specified in the related Prospectus
Supplement. The Prospectus Supplement for an issue of Index Warrants will set
forth the formula pursuant to which the Index Cash Settlement Value will be
determined, including any multipliers, if applicable.
The Prospectus Supplement will describe the terms of Index Warrants offered
thereby, the Index Warrant Agreement relating to such Index Warrants and the
Index Warrant Certificate representing such Index Warrants, including the
following: (1) the title of such Index Warrants; (2) the aggregate amount of
such Index Warrants; (3) the initial offering price of such Index Warrants; (4)
the exercise price, if any;
(5) the currency or currency unit in which the initial offering price, the
exercise price, if any, and the Index Cash Settlement Value of such Index
Warrants is payable; (6) the Index or Indices for such Index Warrants, which may
be based on one or more U.S. or foreign stocks, bonds, or other securities, one
or more U.S. or foreign interest rates, one or more currencies or currency
units, or any combination of the foregoing, and may be a preexisting U.S. or
foreign index compiled and published by a third party or an index based on one
or more securities, interest rates or currencies selected by Holdings solely in
connection with the issuance of such Index Warrants, and certain information
regarding such Index or Indices and the underlying securities, interest rates or
currencies (including, to the extent possible, the policies of the publisher of
the Index with respect to additions, deletions and substitutions of such
securities, interest rates or currencies); (7) whether such Index Warrants shall
be Index Put Warrants, Index Call Warrants, Index Spread Warrants or otherwise;
(8) the method of providing for a substitute Index or Indices or otherwise
determining the amount payable in connection with the exercise of such Index
Warrants if any Index changes or ceases to be made available by its publisher;
(9) the formula for determining the Index Cash Settlement Value, if applicable,
of each Index Warrant; (10) whether and under what circumstances a minimum
and/or maximum expiration value is applicable upon the expiration or exercise of
such Index Warrants; (11) the effect or effects, if any, of the occurrence of a
Market Disruption Event or Force Majeure Event; (12) the date on which the right
to exercise such Index Warrants shall commence and the date (the "Index Warrant
Expiration Date") on which such right shall expire; (13) any minimum number of
Index Warrants which must be exercised at any one time, other than upon
automatic exercise; (14) the maximum number, if any, of such Index Warrants that
may, subject to election by Holdings, be exercised by all owners (or by any
person or entity) on any day; (15) any provisions for the automatic exercise of
such Index Warrants other than at expiration; (16) whether and under what
circumstances such Index Warrants may be cancelled by Holdings prior to their
expiration date; (17) any provisions permitting a Holder to condition any notice
of exercise on the absence of certain specified changes in the Index Value, the
Base Index Value or the Reference Index Value after the date of exercise; (18)
any other procedures and conditions relating to the exercise of such Index
Warrants; (19) the identity of the Index Warrant Agent; (20) any national
securities exchange on which such Index Warrants will be listed; (21)
provisions, if any, for issuing such Index Warrants in certificated form; (22)
if such Index Warrants are not issued in book-entry form, the place or places at
which payments in respect of such Index Warrants are to be made by Holdings;
(23) if applicable, a discussion of certain United States federal income tax,
accounting or other special considerations applicable thereto; and (24) any
other terms of such Index Warrants.
Other important information concerning Index Warrants is set forth below
under "Certain Items Applicable to All Warrants--Modifications", "--Merger,
Consolidation, Sale or Other Dispositions",
"--Enforceability of Rights by Beneficial Owner; Governing Law" and "--Unsecured
Obligations of a
17
<PAGE>
Holding Company" and "Certain Items Applicable to Currency Warrants, Index
Warrants and Interest Rate Warrants--Exercise of Warrants", "--Market Disruption
and Force Majeure Events", "--Settlement Currency" and "--Listing".
INTEREST RATE WARRANTS
Holdings may issue, together with Debt Securities, Debt Warrants, Currency
Warrants or Index Warrants or, separately, Interest Rate Warrants (a) in the
form of Interest Rate Put Warrants, entitling the owners thereof to receive from
Holdings the Interest Rate Cash Settlement Value (as shall be defined in the
Prospectus Supplement) in cash, which amount will be determined by reference to
the amount, if any, by which the Spot Amount (as shall be defined in the
Prospectus Supplement) is less than the Strike Amount (as shall be defined in
the Prospectus Supplement) on the applicable valuation date following exercise,
(b) in the form of Interest Rate Call Warrants, entitling the owners thereof to
receive from Holdings the Interest Rate Cash Settlement Value in cash, which
amount will be determined by reference to the amount, if any, by which the Spot
Amount on the applicable valuation date following exercise exceeds the Strike
Amount or (c) in such other form as shall be specified in the related Prospectus
Supplement. The Prospectus Supplement for an issue of Interest Rate Warrants
will set forth the formula pursuant to which the Interest Rate Cash Settlement
Value will be determined, including any multipliers, if applicable. The Strike
Amount may either be a fixed yield, price or rate of a Debt Instrument, a Rate
or any combination of Debt Instruments and/or Rates or a yield, price or rate
that varies during the term of the Interest Rate Warrants in accordance with a
schedule or formula. The Debt Instrument will be one or more instruments
specified in the applicable Prospectus Supplement issued either by the United
States government or by a foreign government. The Rate will be one or more
interest rates or interest rate swap rates established from time to time by one
or more financial institutions specified in the applicable Prospectus
Supplement.
The Prospectus Supplement will describe the terms of Interest Rate Warrants
offered thereby, the Interest Rate Warrant Agreement relating to such Interest
Rate Warrants and the Interest Rate Warrant Certificate representing such
Interest Rate Warrants, including the following: (1) the title of such Interest
Rate Warrants, (2) the aggregate amount of such Interest Rate Warrants; (3) the
initial offering price of such Interest Rate Warrants; (4) the exercise price,
if any; (5) the currency or currency unit in which the initial offering price,
the exercise price, if any, and the Interest Rate Cash Settlement Value of such
Interest Rate Warrants is payable; (6) the Debt Instrument (which may be one or
more debt instruments issued either by the United States government or by a
foreign government), the Rate (which may be one or more interest rates or
interest rate swap rates established from time to time by one or more specified
financial institutions) or the other yield, price or rate utilized for such
Interest Rate Warrants, and certain information regarding such Debt Instrument
or Rate; (7) whether such Interest Rate Warrants shall be Interest Rate Put
Warrants, Interest Rate Call Warrants or otherwise; (8) the Strike Amount, the
method of determining the Spot Amount and the method of expressing movements in
the yield or closing price of the Debt Instrument or in the level of the Rate as
a cash amount in the currency in which the Interest Rate Cash Settlement Value
of such Warrants is payable; (9) the formula for determining the Interest Rate
Cash Settlement Value, if applicable, of each Interest Rate Warrant; (10)
whether and under what circumstances a minimum and/or maximum expiration value
is applicable upon the expiration or exercise of such Interest Rate Warrants;
(11) the effect or effects, if any, of the occurrence of a Market Disruption
Event or Force Majeure Event; (12) the date on which the right to exercise such
Interest Rate Warrants shall commence and the date (the "Interest Rate Warrant
Expiration Date") on which such right shall expire; (13) any minimum number of
Interest Rate Warrants which must be exercised at any one time, other than upon
automatic exercise; (14) the maximum number, if any, of such Interest Rate
Warrants that may, subject to election by Holdings, be exercised by all owners
(or by any person or entity) on any day; (15) any provisions for the automatic
exercise of such Interest Rate Warrants other than at expiration; (16) whether
and under what circumstances such Interest Rate Warrants may be cancelled by
Holdings prior to their expiration
18
<PAGE>
date; (17) any provisions permitting a Holder to condition any notice of
exercise on the absence of certain specified changes in the Spot Amount after
the date of exercise; (18) any other procedures and conditions relating to the
exercise of such Interest Rate Warrants; (19) the identity of the Interest Rate
Warrant Agent; (20) any national securities exchange on which such Interest Rate
Warrants will be listed; (21) provisions, if any, for issuing such Interest Rate
Warrants in certificated form; (22) if such Interest Rate Warrants are not
issued in book-entry form, the place or places at which payments in respect of
such Interest Rate Warrants are to be made by Holdings; (23) if applicable, a
discussion of certain United States federal income tax, accounting or other
special considerations applicable thereto; and (24) any other terms of such
Interest Rate Warrants.
Other important information concerning Interest Rate Warrants is set forth
below under "Certain Items Applicable to All Warrants--Modifications",
"--Merger, Consolidation, Sale or Other Dispositions", "--Enforceability of
Rights by Beneficial Owner; Governing Law" and "--Unsecured Obligations of a
Holding Company" and "Certain Items Applicable to Currency Warrants, Index
Warrants and Interest Rate Warrants--Exercise of Warrants", "--Market Disruption
and Force Majeure Events", "--Settlement Currency" and "--Listing".
CERTAIN ITEMS APPLICABLE TO ALL WARRANTS
MODIFICATIONS
Each Warrant Agreement and the terms of each issue of Warrants may be
amended by Holdings and the applicable Warrant Agent, without the consent of the
beneficial owners or the registered holders, for the purpose of curing any
ambiguity, or of curing, correcting or supplementing any defective or
inconsistent provision contained therein, or in any other manner which Holdings
may deem necessary or desirable and which will not adversely affect the
interests of the beneficial owners of the then outstanding unexercised Warrants
in any material respect (Section 6.1).
Holdings and each Warrant Agent also may modify or amend the applicable
Warrant Agreement and the terms of the related Warrants, with the consent of the
beneficial owners of not less than a majority in number of the then outstanding
unexercised Warrants affected, provided that no such modification or amendment
that reduces the amount receivable upon exercise, cancellation or expiration,
shortens the period of time during which the Warrants may be exercised or
otherwise materially and adversely affects the exercise rights of the beneficial
owners of the Warrants or reduces the percentage number of outstanding Warrants
the consent of whose beneficial owners is required for modification or amendment
of the applicable Warrant Agreement or the terms of the Warrants may be made
without the consent of the beneficial owners affected thereby (Section 6.1).
MERGER, CONSOLIDATION, SALE OR OTHER DISPOSITIONS
If at any time there is a merger or consolidation involving Holdings or a
sale, transfer, conveyance or other disposition of all or substantially all of
the assets of Holdings, then in any such event the successor or assuming
corporation shall succeed to and be substituted for Holdings, with the same
effect as if it had been named in the applicable Warrant Agreement and in the
applicable Warrants as Holdings. Holdings shall thereupon be relieved of any
further obligation under such Warrant Agreement or under such Warrants, and, in
the event of any such merger, consolidation, sale, transfer, conveyance or other
disposition, Holdings as the predecessor corporation may thereupon or at any
time thereafter be dissolved, wound up or liquidated (Section 6.2 of the Debt
Warrant Agreement and Section 3.2 of each other Warrant Agreement).
19
<PAGE>
ENFORCEABILITY OF RIGHTS BY BENEFICIAL OWNER; GOVERNING LAW
Each Warrant Agent will act solely as an agent of Holdings in connection
with the issuance and exercise of the applicable Warrants and will not assume
any obligation or relationship of agency or trust for or with any owner of a
beneficial interest in any Warrant or with the registered holder thereof
(Section 5.2). A Warrant Agent shall have no duty or responsibility in case of
any default by Holdings in the performance of its obligations under the
applicable Warrant Agreement or Warrant Certificate including, without
limitation, any duty or responsibility to initiate any proceedings at law or
otherwise or to make any demand upon Holdings (Section 5.2). Beneficial owners
may, without the consent of the applicable Warrant Agent, enforce by appropriate
legal action, on their own behalf, their right to exercise their Warrants, to
receive Debt Securities, in the case of Debt Warrants, and to receive payment,
if any, for their Warrants, in the case of Currency Warrants, Index Warrants or
Interest Rate Warrants (Section 4.2 of the Debt Warrant Agreement and Section
3.1 of each other Warrant Agreement). Except as may otherwise be provided in the
Prospectus Supplement relating thereto, each issue of Warrants and the
applicable Warrant Agreement will be governed by and construed in accordance
with the law of the State of New York (Section 6.5).
UNSECURED OBLIGATIONS OF A HOLDING COMPANY
The Warrants are unsecured obligations of Holdings and, therefore, changes
in the perceived creditworthiness of Holdings may be expected to affect trading
prices in Warrants. Since Holdings, as a holding company, does not have any
significant assets other than the equity securities of its subsidiaries, its
cash flow and consequent ability to satisfy its financial obligations, including
Warrants, are dependent upon the earnings of its subsidiaries and the
distribution of those earnings to Holdings, or upon loans or other payments of
funds by those subsidiaries to Holdings. Holdings' subsidiaries, including
Lehman Brothers, are separate and distinct legal entities and will have no
obligation, contingent or otherwise, to pay any amount in respect of Warrants or
to make any funds available therefor, whether by dividends, loans or other
payments. Dividends, loans and other payments by Lehman Brothers are restricted
by net capital and other rules of various regulatory bodies. See "Capital
Requirements." The payment of dividends by Holdings' subsidiaries is contingent
upon the earnings of those subsidiaries and is subject to various business
considerations in addition to net capital requirements and contractual
restrictions. Additionally, since Warrants will be obligations of a holding
company, the ability of holders of Warrants to benefit from any distribution of
assets of any subsidiary upon the liquidation or reorganization of such
subsidiary is subordinate to the prior claims of present and future creditors of
such subsidiary.
CERTAIN ITEMS APPLICABLE TO CURRENCY WARRANTS, INDEX WARRANTS AND INTEREST RATE
WARRANTS
EXERCISE OF WARRANTS
Except as may otherwise be provided in the applicable Prospectus Supplement
relating thereto, (a) each Currency Warrant, Index Warrant and Interest Rate
Warrant will entitle the owner, upon payment of the exercise price, if any, to
receive the applicable Cash Settlement Value of such Warrant, on the applicable
Exercise Date, in each case as such terms will further be defined in the
applicable Prospectus Supplement relating thereto (Section 2.2) and (b) if not
exercised prior to 1:30 p.m., New York City time, on the Business Day preceding
the applicable Warrant Expiration Date, the Warrants will be deemed
automatically exercised on such Warrant Expiration Date (Section 2.3). As
described below, Currency Warrants, Index Warrants and Interest Rate Warrants
may also be deemed to be automatically exercised if they are delisted.
Procedures for exercise of the Currency Warrants, Index Warrants and Interest
Rate Warrants will be set out in the applicable Prospectus Supplement.
20
<PAGE>
MARKET DISRUPTION AND FORCE MAJEURE EVENTS
If so specified in the applicable Prospectus Supplement, following the
occurrence of a Market Disruption Event or Force Majeure Event (as each term
shall be defined therein), the Cash Settlement Value of a Currency Warrant, an
Index Warrant or an Interest Rate Warrant may be determined on a different basis
than under normal exercise of a Warrant or the determination of the applicable
Cash Settlement Value. In addition, if so specified in the applicable Prospectus
Supplement, Currency Warrants, Index Warrants and Interest Rate Warrants may, in
certain circumstances, be cancelled by Holdings prior to their expiration date
and the holders thereof will be entitled to receive only the applicable
Cancellation Amount. The Cancellation Amount may be either a fixed amount or an
amount that varies during the term of the Warrants in accordance with a schedule
or formula.
SETTLEMENT CURRENCY
Currency Warrants, Index Warrants and Interest Rate Warrants will be settled
only in U.S. dollars (unless settlement in a foreign currency is specified in
the applicable Prospectus Supplement and is permissible under applicable law)
and accordingly will not require or entitle an owner to sell, deliver, purchase
or take delivery of the currency, security or other instrument underlying such
Warrants. If any of the Currency Warrants, Index Warrants or Interest Rate
Warrants are sold for, or if the exercise price, if any, is payable in, foreign
currencies or foreign currency units or if the amount payable by Holdings in
respect of any series of Currency Warrants, Index Warrants or Interest Rate
Warrants is payable in foreign currencies or foreign currency units, the
restrictions, elections, tax consequences, specific terms and other information
with respect to such issue of Warrants and such currencies or currency units
will be set forth in an applicable Prospectus Supplement relating thereto.
LISTING
Unless otherwise provided in the Prospectus Supplement, each issue of
Currency Warrants, Index Warrants and Interest Rate Warrants will be listed on a
national securities exchange, as specified in the applicable Prospectus
Supplement, subject only to official notice of issuance, as a pre-condition to
the sale of any such Warrants. It may be necessary in certain circumstances for
such national securities exchange to obtain the approval of the SEC in
connection with any such listing. In the event that such Warrants are delisted
from, or permanently suspended from trading on, such exchange, and, at or prior
to such delisting or suspension, such Warrants shall not have been listed on
another national securities exchange, any such Warrants not previously exercised
will be deemed automatically exercised on the date such delisting or permanent
trading suspension becomes effective (Section 2.3). The applicable Cash
Settlement Value to be paid in such event will be as set forth in the applicable
Prospectus Supplement. Holdings will notify holders of such Warrants as soon as
practicable of such delisting or permanent trading suspension. The applicable
Warrant Agreement will contain a covenant of Holdings not to seek delisting of
such Warrants from, or permanent suspension of their trading on, such exchange
(Section 2.4 of the Currency Warrant Agreement and the Interest Rate Warrant
Agreement and Section 2.5 of the Index Warrant Agreement).
GLOBAL SECURITIES
The Securities of a series may be issued in whole or in part in the form of
one or more Global Securities that will be deposited with or on behalf of a
depository (a "Depository") identified in the Prospectus Supplement relating to
such series. Global Securities representing Debt Securities or Debt Warrants may
be issued in either registered or bearer form. Global Securities representing
Currency Warrants, Index Warrants or Interest Rate Warrants will be issued in
registered form only. Global Securities may be issued in either temporary or
permanent form.
The specific terms of the depository arrangement with respect to any
Securities of a series will be described in the Prospectus Supplement relating
to such series. The Company anticipates that the following provisions will apply
to all depository arrangements.
21
<PAGE>
Unless otherwise specified in an applicable Prospectus Supplement,
Securities which are to be represented by a Global Security in registered form
to be deposited with or on behalf of a Depository will be registered in the name
of such Depository or its nominee. Upon the issuance of a Global Security in
registered form, the Depository for such Global Security will credit the
respective principal amounts, in the case of Debt Securities, and the respective
number of warrants, in the case of Warrants represented by such Global Security
to the accounts of institutions that have accounts with such Depository or its
nominee ("participants"). The accounts to be credited shall be designated by the
underwriters or agents of such Securities or by Holdings, if such Securities are
offered and sold directly by Holdings. Ownership of beneficial interests in such
Global Securities will be limited to participants or persons that may hold
interests through participants. Ownership of beneficial interests by
participants in such Global Securities will be shown on, and the transfer of
that ownership interest will be effected only through, records maintained by the
Depository or its nominee for such Global Security. Ownership of beneficial
interests in Global Securities by persons that hold through participants will be
shown on, and the transfer of that ownership interest within such participant
will be effected only through, records maintained by such participant. The laws
of some jurisdictions require that certain purchasers of securities take
physical delivery of such securities in definitive form. Such limits and such
laws may impair the ability to transfer beneficial interests in a Global
Security.
So long as the Depository for a Global Security in registered form, or its
nominee, is the registered owner of such Global Security, such Depository or
such nominee, as the case may be, will be considered the sole owner or holder of
the Securities represented by such Global Security for all purposes under the
applicable Indenture, in the case of Debt Securities, or under the applicable
Warrant Agreement, in the case of Warrants, governing such Securities. Except as
set forth below, owners of beneficial interests in such Global Security will not
be entitled to have Securities of the series represented by such Global Security
registered in their names, will not receive or be entitled to receive physical
delivery of Securities of such series in definitive form and will not be
considered the owners or holders thereof under the applicable Indenture, in the
case of Debt Securities, or under the applicable Warrant Agreement, in the case
of Warrants.
Payments in respect of Securities registered in the name of or held by a
Depository or its nominee will be made to the Depository or its nominee, as the
case may be, as the registered owner or the holder of the Global Security. None
of Holdings, the underwriters, the applicable Trustee or Warrant Agent, any
Paying Agent or any Security Registrar for such Securities will have any
responsibility or liability for any aspect of the records relating to or
payments made on account of beneficial ownership interests in a Global Security
or for maintaining, supervising or reviewing any records relating to such
beneficial ownership interests.
Holdings expects that the Depository for a permanent Global Security in
registered form, upon receipt of any payment in respect of a permanent Global
Security, will credit immediately participants' accounts with payments in
amounts proportionate to their respective beneficial interests in such Global
Security as shown on the records of such Depository. Holdings also expects that
payments by participants to owners of beneficial interests in such Global
Security held through such participants will be governed by standing
instructions and customary practices, as is now the case with securities held
for the accounts of customers in bearer form or registered in "street name," and
will be the responsibility of such participants.
A Global Security in registered form may not be transferred except as a
whole by the Depository for such Global Security to a nominee of such Depository
or by a nominee of such Depository to such Depository or another nominee of such
Depository or by such Depository or any such nominee to a successor of such
Depository or a nominee of such successor. If a Depository for a permanent
Global Security in registered form is at any time unwilling or unable to
continue as Depository and a successor Depository is not appointed by Holdings
within 90 days, Holdings will issue Securities in definitive registered form in
exchange for the Global Security representing such Securities. In addition,
Holdings may at any time and in its sole discretion determine not to have any
Securities in registered form represented by one or more Global Securities and,
in such event, will issue Securities in definitive form in exchange for all of
the Global Securities representing such Securities. Further, if Holdings so
specifies with
22
<PAGE>
respect to the Securities of a series, an owner of a beneficial interest in a
Global Security representing Securities of such series may, on terms acceptable
to Holdings and the Depository for such Global Security, receive Securities of
such series in definitive form. In any such instance, an owner of a beneficial
interest in a Global Security will be entitled to physical delivery in
definitive form of Securities of the series represented by such Global Security
equal in principal amount, in the case of Debt Securities, or number, in the
case of Warrants, to such beneficial interest and to have such Securities
registered in its name (if the Securities of such series are issuable as
registered securities). Unless otherwise specified by Holdings, Securities of
such series so issued in definitive form will be issued either as registered or
bearer securities (if the Securities of such series are issuable in such form)
and in authorized denominations, in the case of Debt Securities, or in
authorized numbers, in the case of Warrants, as specified in the applicable
Prospectus Supplement. See, however, "Description of Debt
Securities--Limitations on Issuance of Bearer Securities" above for a
description of certain restrictions on the issuance of a Bearer Security in
definitive form in exchange for an interest in a Global Security.
BEARER DEBT SECURITIES
If so specified in an applicable Prospectus Supplement, pending the
availability of a permanent Global Security, all or any portion of the Debt
Securities of a series which may be issuable as bearer securities will initially
be represented by one or more temporary Global Securities, without interest
coupons, to be deposited with a common depositary in London for Morgan Guaranty
Trust Company of New York, Brussels Office, as operator of the Euroclear System
("Euroclear") and Cedel Bank, societe anonyme ("Cedel") for credit to the
designated accounts. The interests of the beneficial owner or owners in such a
temporary Global Security in bearer form will be exchangeable for (i) in whole,
definitive Bearer Securities, (ii) in whole, Senior Debt Securities to be
represented thereafter by one or more permanent Global Securities in bearer
form, without interest coupons, and/or (iii) in whole or in part, definitive
Registered Securities, (the date of such exchange, the "Exchange Date");
provided, however, that if definitive Bearer Securities have previously been
issued in exchange for an interest in a permanent Global Security in bearer form
representing Senior Debt Securities of the same series, then interests in such
Senior Debt Securities (with certain exceptions) shall only thereafter be
exchangeable, in whole, for definitive Bearer Securities, definitive Registered
Securities, or any combination thereof (with certain exceptions) representing
Debt Securities having the same interest rate and Stated Maturity, but only upon
written certification in the form and to the effect described under
"Denominations, Registration and Transfer" unless such certification has been
provided on an earlier interest payment date. The beneficial owner of a Debt
Security represented by a permanent Global Security in bearer form may, on the
applicable Exchange Date and upon 30 days' notice to the applicable Trustee
given through Euroclear or Cedel, exchange its interest in whole for definitive
Bearer Securities or, if specified in an applicable Prospectus Supplement, in
whole or in part, for definitive Registered Securities of any authorized
denomination, provided, however, that if definitive Bearer Securities are issued
in partial exchange for Senior Debt Securities represented by such permanent
Global Security or by a temporary Global Security in bearer form of the same
series, such issuance (with certain exceptions) shall give rise to the exchange
of such permanent Global Security in whole for, at the option of the Holders,
definitive Bearer Securities, definitive Registered Securities, or any
combination thereof. No Bearer Security delivered in exchange for a portion of a
permanent Global Security shall be mailed or otherwise delivered to any location
in the United States in connection with such exchange.
Unless otherwise specified in an applicable Prospectus Supplement, interest
in respect of any portion of such a temporary Global Security in bearer form
payable in respect of an Interest Payment Date occurring prior to the issuance
of a permanent Global Security in bearer form will be paid to each of Euroclear
and Cedel with respect to the portion of the temporary Global Security in bearer
form held for its account. Each of Euroclear and Cedel will undertake in such
circumstances to credit such interest received by it in respect of a temporary
Global Security in bearer form to the respective accounts for which it holds
such temporary Global Security in bearer form as of the relevant Interest
Payment Date, but only upon receipt in each case of written certification, in
the form and to the effect described under "Description of Debt
Securities--Denomination, Registration and Transfer."
23
<PAGE>
UNITED STATES TAXATION
A summary of the material U.S. federal income tax consequences to U.S.
persons investing in Securities will be set forth in the applicable Prospectus
Supplement. The summary of U.S. federal income tax consequences contained in the
Prospectus Supplement will be presented for informational purposes only,
however, and will not be intended as legal or tax advice to prospective
purchasers. Prospective purchasers of Securities are urged to consult their own
tax advisors prior to any acquisition of Securities.
CAPITAL REQUIREMENTS
As a registered broker-dealer, Lehman Brothers is subject to the SEC's net
capital rule (Rule 15c3-1, the "Net Capital Rule"), promulgated under the
Exchange Act. The Exchange monitors the application of the Net Capital Rule by
Lehman Brothers. Lehman Brothers computes net capital under the alternative
method of the Net Capital Rule which requires the maintenance of minimum net
capital, as defined. A broker-dealer may be required to reduce its business if
its net capital is less than 4% of aggregate debit balances and may also be
prohibited from expanding its business or paying cash dividends if resulting net
capital would be less than 5% of aggregate debit balances. In addition, the Net
Capital Rule does not allow withdrawal of subordinated capital if net capital
would be less than 5% of such debit balances.
The Net Capital Rule also limits the ability of broker-dealers to transfer
large amounts of capital to parent companies and other affiliates. Under the Net
Capital Rule equity capital cannot be withdrawn from a broker-dealer without the
prior approval of the SEC when net capital after the withdrawal would be less
than 25% of its securities positions haircuts (which are deductions from capital
of certain specified percentages of the market value of securities to reflect
the possibility of a market decline prior to disposition). In addition, the Net
Capital Rule requires broker-dealers to notify the SEC and the appropriate
self-regulatory organization two business days before a withdrawal of excess net
capital if the withdrawal would exceed the greater of $500,000 or 30% of the
broker-dealer's excess net capital, and two business days after a withdrawal
that exceeds the greater of $500,000 or 20% of excess net capital. Finally, the
Net Capital Rule authorizes the SEC to order a freeze on the transfer of capital
if a broker-dealer plans a withdrawal of more than 30% of its excess net capital
and the SEC believes that such a withdrawal would be detrimental to the
financial integrity of the firm or would jeopardize the broker-dealer's ability
to pay its customers.
Compliance with the Net Capital Rule could limit those operations of Lehman
Brothers that require the intensive use of capital, such as underwriting and
trading activities and the financing of customer account balances, and also
could restrict Holdings' ability to withdraw capital from Lehman Brothers which
in turn could limit Holdings' ability to pay dividends, repay debt and redeem or
purchase shares of its outstanding capital stock.
The Company is subject to other domestic and international regulatory
requirements with which it is required to comply.
PLAN OF DISTRIBUTION
Holdings may sell Securities in any one or more of the following ways: (i)
through, or through underwriting syndicates managed by, Lehman Brothers alone or
with one or more other underwriters; (ii) through one or more dealers or agents
(which may include Lehman Brothers); or (iii) directly to one or more
purchasers. The specific managing underwriter or underwriters or agent or agents
with respect to the offer and sale of Securities are set forth on the cover of a
Prospectus Supplement relating to such Securities and the members of the
underwriting syndicate, if any, are named in such Prospectus Supplement. Only
the underwriters or agents so named in a Prospectus Supplement are underwriters
or agents, respectively, in connection with such Securities. The applicable
Prospectus Supplement also describes the discounts and commissions to be allowed
or paid to the underwriters or agents, all other items constituting
24
<PAGE>
underwriting or agency compensation, the discounts and commissions to be allowed
or paid to dealers, if any, and the exchanges, if any, on which such Securities
will be listed.
Securities acquired by any underwriter will be acquired for its own account
and may be resold from time to time in one or more transactions, including
negotiated transactions, at a fixed public offering price or at varying prices
determined at the time of sale. The obligations of the underwriters to purchase
such Securities will be subject to certain conditions precedent, and the
underwriters will be obligated to purchase all such Securities if any of such
Securities are purchased. Any initial public offering price and any discounts or
concessions allowed or reallowed or paid to dealers may be changed from time to
time. To the extent, if any, that Securities to be purchased by Lehman Brothers,
as underwriter, are not resold by it or are not resold at the public offering
price set forth in an applicable Prospectus Supplement, the funds derived from
such offering by the Company on a consolidated basis may be reduced.
If so indicated in an applicable Prospectus Supplement, Holdings will
authorize the underwriters named therein to solicit offers to certain
institutional investors to purchase Securities providing for payment and
delivery on a future date specified in an applicable Prospectus Supplement.
There may be limitations on the minimum amount which may be purchased by any
such institutional investor or on the portion of the aggregate proceeds to
Holdings of the particular Securities which may be sold pursuant to such
arrangements. Institutional investors to which such offers may be made, when
authorized, include commercial and savings banks, insurance companies, pension
funds, educational charitable institutions and such other institutions as may be
approved by Holdings. The obligations of any such purchasers pursuant to such
delayed delivery and payment arrangements will not be subject to any conditions
except (i) the purchase by an institution of the particular Securities shall not
at the time of delivery be prohibited under the laws of any jurisdiction in the
United States to which such institution is subject, and (ii) Holdings shall have
sold to such underwriters all of such Securities less the amount of such
securities covered by such arrangements. Underwriters named therein will not
have any responsibility in respect of the validity of such arrangements or the
performance of Holdings or such institutional investors thereunder.
Each distributor of Bearer Securities will agree that it will not offer or
sell during the restricted period, directly or indirectly, Bearer Securities in
the United States or to United States persons (other than as discussed under
"Description of Debt Securities--Limitations on Issuance of Bearer Securities")
and in connection with the sale of Bearer Securities during the restricted
period, will not deliver definitive Bearer Securities within the United States.
See "Description of Debt Securities--Limitations on Issuance of Bearer
Securities."
Each underwriter or agent will represent and agree that (i) it has not
offered and sold and will not offer or sell, prior to the date six months after
the date of issue in the case of the Debt Securities, any Securities to persons
in the United Kingdom, except to persons whose ordinary activities involve them
in acquiring, holding, managing or disposing of investments (as principal or
agent) for the purposes of their businesses or otherwise in circumstances which
have not resulted and will not result in an offer to the public in the United
Kingdom within the meaning of the Public Offer of Securities Regulations 1995;
(ii) it has complied with and will comply with all applicable provisions of the
Financial Services Act 1986 with respect to anything done by it in relation to
the Securities in, from or otherwise involving the United Kingdom; and (iii) it
has only issued or passed on and will only issue or pass on in the United
Kingdom any document received by it in connection with the issue of the
Securities to a person who is of a kind described in Article 11(3) of the
Financial Services Act 1986 (Investment Advertisements) (Exemptions) Order 1995
or is a person to whom such document may otherwise lawfully be issued or passed
on.
The underwriters and agents named in an applicable Prospectus Supplement may
be entitled under agreements entered into with Holdings to indemnification by
Holdings against certain civil liabilities, including liabilities under the
Securities Act, or to contribution with respect to payments which the
underwriters and agents may be required to make in respect thereof. The
underwriters and agents may engage in transactions with, or perform services
for, Holdings in the ordinary course of business.
25
<PAGE>
This Prospectus together with an applicable Prospectus Supplement may also
be used by Lehman Brothers in connection with offers and sales of Securities
related to market making transactions by and through Lehman Brothers at
negotiated prices related to prevailing market prices at the time of sale.
Lehman Brothers may act as principal or agent in such transactions. Lehman
Brothers is not obligated to make a market in any Securities and may discontinue
any market-making activities at any time without notice. No assurance can be
given that there will be a secondary market for the Securities.
The underwriting and agency arrangements for any offering of the Securities
will comply with the requirements of Rule 2720 of the NASD regarding an NASD
member firm's participating in distributing its affiliate's securities.
ERISA MATTERS
Each of Holdings and Lehman Brothers may be considered a "party in interest"
within the meaning of the Employee Retirement Income Security Act of 1974, as
amended ("ERISA"), and a "disqualified person" under corresponding provisions of
the Code, with respect to certain employee benefit plans. Certain transactions
between an employee benefit plan and a party in interest or disqualified person
may result in "prohibited transactions" within the meaning of ERISA and the
Code. ANY EMPLOYEE BENEFIT PLAN PROPOSING TO INVEST IN THE SECURITIES SHOULD
CONSULT WITH ITS LEGAL COUNSEL.
LEGAL OPINIONS
Unless otherwise indicated in an applicable Prospectus Supplement relating
to offered Securities, the validity of the Securities offered hereby will be
passed upon for Holdings by Karen M. Muller, Esq., Deputy General Counsel of
Holdings and for the underwriters or agents by Simpson Thacher & Bartlett (a
partnership which includes professional corporations), 425 Lexington Avenue, New
York, New York 10017. Simpson Thacher & Bartlett acts as counsel in various
matters for Holdings, Lehman Brothers and certain of their subsidiaries.
INDEPENDENT ACCOUNTANTS
The consolidated financial statements and schedules of the Company for the
year ended November 30, 1996, the year ended November 30, 1995 and for the
eleven months ended November 30, 1994, appearing in the Company's Annual Report
on Form 10-K for the year ended November 30, 1996, have been audited by Ernst &
Young LLP, independent auditors, as set forth in their report thereon included
therein and incorporated herein by reference. Such consolidated financial
statements and schedules are incorporated herein by reference in reliance upon
the reports of Ernst & Young LLP pertaining to such financial statements given
upon the authority of such firm as experts in accounting and auditing.
26
<PAGE>
$13,000,000
-----------
LEHMAN BROTHERS HOLDINGS INC.
Notes Due November 14, 2007
Performance Linked to Pfizer Inc. (PFE) Common Stock
Prospectus Supplement
November 9, 2000
(Including Prospectus dated
February 17, 1998)
------------------
Lehman Brothers
